Companies news of 2009-10-13 (page 1)

  • Canadian Solar Expects 3Q 2009 Shipments to Exceed Prior Guidance; Company Raises Full...
  • Conseco Announces Proposed Registered Offering of Common Stock
  • Buenaventura Announces Results of Extraordinary Shareholders Meeting
  • Amylin Pharmaceuticals to Webcast Third Quarter Results
  • Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast
  • Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide...
  • Conseco Announces that Paulson Agrees to Buy Common Stock and Warrants
  • EXFO Reports Fourth-Quarter and Year-End Results for Fiscal 2009- Annual sales decrease...
  • CSX Announces Third Quarter Earnings
  • Sealy to Present at the Wells Fargo Consumer Conference
  • AirTran Airways and the Atlanta Falcons Launch Falcons 1- Custom Painted Boeing 717 Makes...
  • Advanced Energy to Report Third Quarter 2009 Financial Results Before Market Open
  • Medifast, Inc. Announces Appointment of Three Additional Independent Board Members
  • Hillman Group Capital Trust Announces Cash Distribution on Trust Preferred Securities
  • Anixter International Announces Third Quarter 2009 Earnings Conference Call
  • Nanophase Technologies Announces Third Quarter 2009 Financial Conference Call
  • Telephone access available for Inmet Mining third quarter conference call
  • Infosys Honored With Oracle Titan Partner Award at Oracle(R) OpenWorld 2009Recognized for...
  • ArvinMeritor Hosts Conference Call and Web Cast to Present Fourth-Quarter and Full-Year...
  • Graffiti Entertainment to License USA Racquetball for New Racquetball Videogame for...
  • MedQuist Announces Reseller Agreement With ClarioTechnology integration improves...
  • New York State Agencies Collecting Used Cell Phones to Benefit Domestic Violence...
  • Video: H&R Block Helps Prepare Teens to be Financially Fit in the Real World
  • Bebida Beverages In Alliance With Potencia USA Introduce New Distribution Partner
  • Grandunion Inc. Acquires Control of Aries Maritime Transport Limited
  • First South Bancorp, Inc. Reports September 30, 2009 Quarterly and Nine Months Earnings
  • Raptor Pharmaceutical annonce des résultats intermédiaires positifs de ses essais...
  • Savvis Announces Time for Third Quarter 2009 Earnings Call
  • Land Star Inc (LDSR) No Recapitalization and No Dilution Policy In EffectCompany Featured...



    Canadian Solar Expects 3Q 2009 Shipments to Exceed Prior Guidance; Company Raises Full Year 2009 Guidance

    ONTARIO, Canada, Oct. 13 /PRNewswire-Asia-FirstCall/ -- Canadian Solar Inc. ("the Company," "Canadian Solar" or "we") today announced that based on selected unaudited financial results, it expects shipments for the third quarter of 2009 will exceed the high-end of its prior guidance. The Company also announced it is raising its guidance for the full year of 2009.

    Based on its selected unaudited financial results, Canadian Solar believes that its net revenues for the third quarter of 2009 will be approximately $210 million to $215 million, with shipments of approximately 101 MW to 103 MW, compared to prior guidance for shipments of approximately 90 MW to 100 MW. We expect to report a gross margin of 16% to 17% for the third quarter of 2009.

    Based on the high level of interest in Canadian Solar's products at the Hamburg trade show and subsequent purchase orders, the Company is raising its guidance for full year 2009 shipments to approximately 295 MW to 305 MW, including expected shipments of 127 MW to 137 MW for the fourth quarter of 2009. This compares to prior guidance for shipments of approximately 260 MW to 270 MW for the full year 2009, and earlier full year 2009 guidance of 200 MW to 220 MW. The Company continues to make improvements in its cost structure, which it expects will positively impact ongoing profitability.

    Dr. Shawn Qu, Chairman and CEO said: "Demand has continued to be strong among our core customer group as well as among new customers. We anticipate that Q4 2009 will be even stronger than Q3 2009 in terms of shipments and we expect to maintain similar gross margins. We plan to increase our solar module manufacturing capacity to 1 GW, our solar cell capacity to 700 MW and our ingot and wafer capacity to 350 MW by the end of 2010 to meet demand levels."

    No conference call will be held in conjunction with this guidance update. Additional information related to the third quarter and full year 2009 will be available when the Company reports its third quarter 2009 results on Tuesday, November 24, 2009. The above outlook is based on the Company's current views with respect to operating and market conditions, which are subject to change. The risks to its guidance also include changes in product pricing and the project financing environment.

    About Canadian Solar Inc.

    Canadian Solar Inc. is a leading vertically integrated provider of ingot, wafer, solar cell, solar module and other solar applications. Canadian Solar designs, manufactures and delivers solar products and solar systems for on-grid and off-grid use to customers worldwide. Canadian Solar is one of the world's largest solar module producers by manufacturing capacity. With operations in North America, Europe and Asia, Canadian Solar provides premium quality, cost-effective and environmentally-friendly solar solutions to support global sustainable development. For more information, visit http://www.canadian-solar.com .

    Safe Harbor/Forward-Looking Statements

    Certain statements in this press release, including statements regarding expected future production capacities, market demand, product shipment volumes, revenues and profitability, are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "believes," "expects," "anticipates," "intends," "estimates," the negative of these terms, or other comparable terminology. Factors that could cause actual results to differ include general business and economic conditions and the state of the solar industry; governmental support for the deployment of solar power; future shortage or availability of the supply of high-purity silicon; demand for end-use products by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers, including customers of our silicon materials sales; changes in demand from major markets such as Germany and the Czech Republic; changes in customer order patterns; seasonal weather patterns; changes in product mix; capacity utilization; level of competition; pricing pressure and declines in average selling prices; delays in new product introduction; continued success in technological innovations and delivery of products with the features customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange rate fluctuations; litigation and other risks as described in the Company's SEC filings, including its annual report on Form 20-F originally filed on June 8, 2009, as amended by the Company's report on Form 20-F/A, filed on October 13, 2009. Although the Company believes that the expectations reflected in the forward looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.

    Canadian Solar Inc.

    CONTACT: In Canada, Alex Taylor, IR Director, Canadian Solar Inc.,
    +1-519-954-2057, Fax +1-519-954-2597, or ir@csisolar.com; In the U.S., David
    Pasquale, Global IR Partners, +1-914-337-8801, or csiq@globalirpartners.com




    Conseco Announces Proposed Registered Offering of Common Stock

    CARMEL, Ind., Oct. 13 /PRNewswire-FirstCall/ -- Conseco, Inc. announced today that it plans to file a registration statement with the Securities and Exchange Commission relating to a proposed registered offering of common stock that would generate not less than $200 million in gross proceeds to Conseco.

    In connection with its concurrently announced agreement to privately sell to investment funds managed by Paulson & Co. Inc. 16.4 million shares of common stock and warrants to purchase 5.0 million shares of common stock, Conseco has agreed, to the extent such offering of common stock does not jeopardize Conseco's ability to use its existing net operating loss carry-forwards, that it will use its reasonable best efforts to consummate the proposed registered offering no later than 120 days after the consummation of the cash tender offer for Conseco's 3.50% Convertible Debentures due September 30, 2035 that Conseco intends to commence in the near future (which 120th day Conseco currently expects to be March 12, 2010). There can be no assurance that Conseco will be able to complete the proposed registered offering by the 120th day after the consummation of the cash tender offer, in such amount, or at all. Conseco is currently required to use half of the net proceeds of any such issuance to repay indebtedness under its credit agreement. The remaining net proceeds would be used for general corporate purposes.

    This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any offer or sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the Securities Act of 1933, as amended, and applicable securities laws of any such state or jurisdiction.

    Details of the intended tender offer for Conseco's existing convertible debentures will be provided in an offer to purchase and related documents, which will be filed with the Securities and Exchange Commission as exhibits to a Schedule TO. Holders of the existing convertible debentures are advised to read the Schedule TO and the exhibits thereto because they will contain important information. Holders of the existing convertible debentures may obtain copies of the documents Conseco files with the Securities and Exchange Commission, including the Schedule TO and related exhibits, free from the Securities and Exchange Commission's website, which may be accessed at http://www.sec.gov/, and the investor relations section of Conseco's website, which may be accessed at http://investor.conseco.com/.

    About Conseco

    Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, critical illness and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures.

    Cautionary Statement Regarding Forward-Looking Statements. The statements, trend analyses and other information contained in this press release and elsewhere (such as in filings by Conseco with the SEC, presentations by Conseco or its management or oral statements) relative to markets for Conseco's products and trends in the Conseco's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate, " "believe, " "plan, " "estimate, " "expect, " "project, " "intend," "may, " "will, " "would, " "contemplate, " "possible, " "attempt, " "seek, " "should, " "could, " "goal, " "target, " "on track, " "comfortable with," "optimistic" and similar words, although some forward-looking statements are expressed differently. Statements that contain these words should be considered carefully because they describe the Conseco's expectations, plans, strategies and goals and the Conseco's beliefs concerning future business conditions, the Conseco's results of operations, financial position, and the Conseco's business outlook or they state other "forward-looking" information based on currently available information. The "Risk Factors" section of Conseco's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q provides examples of risks, uncertainties and events that could cause the Conseco's actual results to differ materially from the expectations expressed in forward-looking statements. All written or oral forward-looking statements attributable to Conseco are expressly qualified in their entirety by the foregoing cautionary statement. The forward-looking statements speak only as of the date made. Conseco assumes no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.

    Conseco, Inc.

    CONTACT: (News Media) Tony Zehnder, Corporate Communications,
    +1-312-396-7086, (Investors) Scott Galovic, Investor Relations,
    +1-317-817-3228, Conseco, Inc.

    Web Site: http://www.conseco.com/




    Buenaventura Announces Results of Extraordinary Shareholders Meeting

    LIMA, Peru, Oct. 13 /PRNewswire-FirstCall/ -- Compania de Minas Buenaventura S.A.A. ("Buenaventura") (NYSE: BVN; Lima Stock Exchange: BUE.LM), Peru's largest publicly traded precious metals mining company, announced the granting of authority to the Company's Board of Director's to decide the convenience to purchase from Compania Minera Condesa S.A., and via the equity market, 21,160,260 shares issued by the company that owns Condesa, as well as delegating to Buenaventura's Board of Directors the authority to establish the final purpose of the shares previously mentioned.

    Company Description

    Compania de Minas Buenaventura S.A.A. is Peru's largest, publicly traded, precious metals company and a major holder of mining rights in Peru. The Company is engaged in the mining, processing, development and exploration of gold and silver and other metals via wholly owned mines as well as through its participation in joint exploration projects.

    Buenaventura currently operates several mines in Peru (Orcopampa, Uchucchacua, Antapite, Julcani, Recuperada and Caraveli), has controlling interest in two mining companies (CEDIMIN and El Brocal), as well as a minority interest in several other mining companies in Peru. The Company owns 43.65% in Minera Yanacocha S.R.L. (a partnership with Newmont Mining Corporation), an important precious metal producer, and 19.22% in Sociedad Minera Cerro Verde, an important Peruvian copper producer.

    To request a printed version of the Company's 2008 annual report on Form 20-F, contact the persons below.

    Cautionary Statement

    This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the safe harbor created by such sections. Such forward-looking statements include, without limitation, statements regarding future mining or permitting activities. Where Buenaventura expresses or implies an expectation or belief as to future events or results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include those concerning the Company's, Yanacocha's and Cerro Verde's costs and expenses, results of exploration, the continued improving efficiency of operations, prevailing market prices of gold, silver and other metals mined, the success of joint ventures, estimates of future explorations, development and production, subsidiaries' plans for capital expenditures, estimates of reserves and Peruvian political, economical, legal and social developments. For a more detailed discussion of such risks and other factors, see the company's 2006 Annual Report on Form 20-F, which is on file with the Securities and Exchange Commission, as well as the company's other SEC filings. Buenaventura does not undertake any obligation to release publicly revisions to any "forward-looking statement," to reflect events or circumstances after the date of this news release, or to reflect the occurrence of unanticipated events, except as may be required under applicable securities laws.

    Contacts in Lima: Roque Benavides/Carlos Galvez Compania de Minas Buenaventura S.A.A. Tel: (511) 419-2538/419-2540 Investor Relations: Daniel Dominguez Tel: (511) 419-2536 Email: ddominguez@buenaventura.com.pe Contacts in New York: Maria Barona/Peter Majeski i-advize Corporate Communications, Inc. Tel: (212) 406-3690 Email: buenaventura@i-advize.com

    Compania de Minas Buenaventura S.A.A.

    CONTACT: Contacts in Lima: Roque Benavides or Carlos Galvez,
    +011-511-419-2538, +011-511-419-2540, or Investor Relations: Daniel Dominguez,
    +011-511-419-2536, ddominguez@buenaventura.com.pe, all of Compania de Minas
    Buenaventura; or Contacts in New York: Maria Barona or Peter Majeski, both of
    i-advize Corporate Communications, +1-212-406-3690, buenaventura@i-advize.com,
    for Compania de Minas Buenaventura

    Web site: http://www.buenaventura.com.pe/




    Amylin Pharmaceuticals to Webcast Third Quarter Results

    SAN DIEGO, Calif., Oct. 13, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will webcast its Quarterly Update Conference Call for the third quarter of 2009 on Tuesday, October 20, 2009 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. On the same date post-market, Amylin will release financial results for the third quarter of 2009.

    The call will be webcast live through Amylin's corporate Web site and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com/ approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (866) 730-5763 (U.S./Canada) or (857) 350-1587 (international), conference access code 44746855. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (888) 286-8010 (U.S./Canada) or (617) 801-6888 (international), conference access code 78094555.

    About Amylin

    Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com/.

    Amylin Pharmaceuticals, Inc.

    CONTACT: Media, Alice Izzo, +1-858-642-7272, alice.izzo@amylin.com, or
    Investors, Michael York, +1-858-458-8602, michael.york@amylin.com, both of
    Amylin Pharmaceuticals, Inc.

    Web Site: http://www.amylin.com/




    Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast

    SUNNYVALE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cepheid today announced that it will report financial results for its third quarter ended September 30, 2009, on Wednesday, October 28, 2009, after the close of the market.

    The company will host a management presentation at 2 p.m. Pacific Time on Wednesday, October 28, 2009, to discuss the results. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

    Interested participants and investors may also listen to the live teleconference call by dialing (866) 783-2142 (domestic) or (857) 350-1601 (international), and entering participant code 30186203. A replay will be available for seven days beginning at 4 p.m. Pacific Time. Access numbers for this replay are (888) 286-8010 (domestic) and (617) 801-6888 (international), with participant code 49827607.

    About Cepheid

    Based in Sunnyvale, Calif., Cepheid is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com/ for more information.

    CONTACTS: For Media Inquiries: For Investor Inquiries: Jared Tipton Jacquie Ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400 8377 Tel: (408) 400 8329 jared.tipton@cepheid.com investor.relations@cepheid.com

    Cepheid

    CONTACT: media, Jared Tipton, Corporate Communications, +1-408-400-8377,
    jared.tipton@cepheid.com, or investors, Jacquie Ross, Investor Relations,
    +1-408-400-8329, investor.relations@cepheid.com, both of Cepheid

    Web Site: http://www.cepheid.com/




    Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations

    SUNNYVALE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cepheid today announced that it has appointed Mr. Nicolaas ('Nico') Arnold to the position of Executive Vice President of Worldwide Commercial Operations, effective October 14, 2009. The addition of this role expands Cepheid's marketing and sales leadership, and is expected to accelerate the GeneXpert® System's current installed base of more than 1,100 systems globally. Mr. Robert Koska, Cepheid's Senior Vice President of North American Commercial Operations, and Ms. Rika Dutau, Vice President and Managing Director of European Commercial Operations, will continue in their roles, reporting to Mr. Arnold.

    Mr. Arnold joins Cepheid from Siemens and, previously, from Diagnostic Products Corporation which was acquired by Siemens in 2006. Building on his academic and early research experience in clinical laboratories, Mr. Arnold brings more than 25 years of global sales and marketing experience in diagnostics to Cepheid. Most recently, Mr. Arnold was Regional Vice President for Siemens Healthcare Diagnostics in Northwest Europe with responsibility for molecular diagnostics, central lab and point of care sales. Previous roles included Managing Director of European sales for Siemens Medical Diagnostics, with responsibility for more than $1 billion in sales annually, and Vice President of Global Marketing and US Sales for Diagnostic Product Corporation, with total revenues in excess of $500 million.

    "With the initiation of shipment of our high throughput Infinity-48 System and the continued expansion of our GeneXpert System test menu, Cepheid is well positioned for its next phase of growth. It is in this regard that we are extremely pleased to welcome such an accomplished sales and marketing executive to the Cepheid team," said John Bishop, Cepheid's Chief Executive Officer. "We are looking to grow both our domestic and international markets, and this is a timely appointment that further strengthens our sales and marketing capabilities with the objective of establishing the GeneXpert System as the molecular platform of choice."

    In connection with his employment, the Board of Directors of Cepheid has granted Mr. Arnold an option to purchase 200,000 shares of Cepheid common stock at the closing price of Cepheid common stock on the date that his employment starts. This option will become exercisable by Mr. Arnold over four years, with 25% vesting on the one-year anniversary of grant and ratably monthly thereafter, and will expire after seven years from the grant date. This option is granted as an inducement grant pursuant to Section 5635(c)(4) of the Nasdaq Marketplace Rules.

    Cepheid Third Quarter Earnings Announcement

    In a separate press release, Cepheid also announced today that its Third Quarter Earnings Announcement would take place on Wednesday, October 28, 2009, after the close of the market. While detailed financial results are not yet available, the Company currently expects total revenue for the third quarter to be approximately $41 million, representing a solid performance for the quarter.

    In conjunction with the earnings release, the company will host a management presentation at 2 p.m. Pacific Time on Wednesday, October 28, 2009, to discuss the results. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

    Interested participants and investors may also listen to the live teleconference call by dialing (866) 783-2142 (domestic) or (857) 350-1601 (international), and entering participant code 30186203. A replay will be available for seven days beginning at 4 p.m. Pacific Time. Access numbers for this replay are (888) 286-8010 (domestic) and (617) 801-6888 (international), with participant code 49827607.

    Forward-Looking Statements

    This press release contains forward-looking statements that are not purely historical regarding Cepheid's or its management's expectations regarding future revenues and market growth. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the company's current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: the fact that Cepheid's review of its quarterly financial statements is not yet complete, and therefore, final revenues may change as a result; the uncertain impact of the significant global economic downturn on our business, and that of our customers, potential customers and business partners; our success in increasing direct sales and the effectiveness of new sales personnel; the performance and market acceptance of new products; sufficient customer demand; our ability to develop and complete clinical trials successfully in a timely manner for new products; uncertainties related to the FDA regulatory and European regulatory processes; the level of testing at clinical customer sites; changes in the protocols or levels of testing for Healthcare Associated Infections (HAIs); the company's ability to successfully introduce and sell products in clinical markets other than HAIs; unforeseen development and manufacturing problems; the potential need for additional intellectual property licenses for tests and other products and the terms of such licenses; lengthy sales cycles in certain markets; the company's reliance on distributors in some regions to market, sell and support its products; the impact of competitive products and pricing; and the company's ability to manage geographically-dispersed operations. All forward-looking statements and reasons why results might differ included in this release are made as of the date of this press release, based on information currently available to Cepheid, and Cepheid assumes no obligation to update any such forward-looking statement or reasons why results might differ.

    About Cepheid

    Based in Sunnyvale, Calif., Cepheid is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com/ for more information.

    CONTACTS: For Media Inquiries: For Investor Inquiries: Jared Tipton Jacquie Ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400 8377 Tel: (408) 400 8329 jared.tipton@cepheid.com investor.relations@cepheid.com

    Cepheid

    CONTACT: Media, Jared Tipton, Corporate Communications, +1-408-400-8377,
    jared.tipton@cepheid.com, or Investors, Jacquie Ross, Investor Relations,
    +1-408-400-8329, investor.relations@cepheid.com, both of Cepheid

    Web Site: http://www.cepheid.com/




    Conseco Announces that Paulson Agrees to Buy Common Stock and Warrants

    CARMEL, Ind., Oct. 13 /PRNewswire-FirstCall/ -- Conseco, Inc. announced today that, as part of a series of transactions intended to enhance its capital position, it entered into a stock and warrant purchase agreement with Paulson & Co. Inc., on behalf of the several investment funds and accounts managed by it (collectively, "Paulson"), to sell to Paulson 16.4 million shares of common stock and warrants to purchase 5.0 million shares of common stock for an aggregate purchase price of $77.9 million. In addition, Conseco announced its intention to privately offer, subject to certain conditions, up to $293.0 million aggregate principal amount of convertible senior debentures to fund a substantial portion of the purchase price of its existing convertible debentures that are tendered in a cash tender offer for its existing convertible debentures that Conseco intends to commence in the near future.

    Upon closing the private sale of common stock, Paulson will own approximately 9.9% of Conseco's outstanding shares, including shares Paulson previously acquired in open market transactions. Conseco will grant certain registration rights to Paulson in connection with its acquisition of the common stock and warrants. Half of the net proceeds from the issuance of these shares will be used to repay indebtedness under Conseco's credit agreement. The remaining net proceeds will be used:

    -- to pay the portion of the purchase price of the existing convertible debentures that are tendered in the cash tender offer that Conseco intends to commence for such debentures (or any subsequent issuer tender offer that expires on or prior to October 5, 2010) that is not funded by the issuance of new convertible debentures; -- to pay the portion of the repurchase price of the existing convertible debentures on September 30, 2010 that Conseco is required by the holders thereof to repurchase that is not funded by the issuance of new convertible debentures, if any; -- to pay the portion of the redemption price of existing convertible debentures on October 5, 2010 that is not funded by the issuance of new convertible debentures, if any existing convertible debentures remain outstanding at that time and Conseco elects to redeem such existing convertible debentures; and -- for general corporate purposes.

    The warrants that Paulson will receive will have an exercise price of $6.50 per share of common stock, subject to customary anti-dilution adjustments. Prior to June 30, 2013, the warrants will not be exercisable, except under limited circumstances. Commencing on June 30, 2013, the warrants will be exercisable for shares of Conseco's common stock at the option of the holder at any time. The warrants expire on December 30, 2016. The closing of the common stock and warrant sale is subject to satisfaction of certain conditions and is expected to occur on the earliest closing date for the new convertible debentures that Conseco intends to privately offer.

    The issuance of the 16.4 million shares of common stock and warrants to purchase 5.0 million shares of common stock to Paulson together with the issuance of new convertible debentures that Conseco intends to offer, which will be convertible into shares of common stock, will exceed the 20% threshold set forth in Section 312.03 of the New York Stock Exchange (the "NYSE") Listed Company Manual. While the rules of the NYSE generally require stockholder approval prior to the issuance of securities in excess of the 20% threshold, the NYSE's Shareholder Approval Policy provides an exception in cases where the delay involved in securing stockholder approval for the issuance would seriously jeopardize the financial viability of the listed company. In accordance with the NYSE rule providing that exception, the Audit Committee of Conseco's Board of Directors has expressly approved Conseco's intended use of the exception. The NYSE has approved Conseco's reliance on the exception in connection with Conseco's private sale of common stock and warrants to Paulson and the new convertible debentures that Conseco intends to privately offer and, in accordance with such exception, Conseco will not consummate the transactions until at least 10 days after the mailing of a letter to stockholders describing the transactions.

    This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities. The common stock and warrants being sold to Paulson have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

    Details of the intended tender offer for Conseco's existing convertible debentures will be provided in an offer to purchase and related documents, which will be filed with the Securities and Exchange Commission as exhibits to a Schedule TO. Holders of the existing convertible debentures are advised to read the Schedule TO and the exhibits thereto because they will contain important information. Holders of the existing convertible debentures may obtain copies of the documents Conseco files with the Securities and Exchange Commission, including the Schedule TO and related exhibits, free from the Securities and Exchange Commission's website, which may be accessed at http://www.sec.gov/, and the investor relations section of Conseco's website, which may be accessed at http://investor.conseco.com/.

    About Conseco

    Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, critical illness and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures.

    Cautionary Statement Regarding Forward-Looking Statements. The statements, trend analyses and other information contained in this press release and elsewhere (such as in filings by Conseco with the SEC, presentations by Conseco or its management or oral statements) relative to markets for Conseco's products and trends in the Conseco's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate, " "believe, " "plan, " "estimate, " "expect, " "project, " "intend," "may, " "will, " "would, " "contemplate, " "possible, " "attempt, " "seek, " "should, " "could, " "goal, " "target, " "on track, " "comfortable with," "optimistic" and similar words, although some forward-looking statements are expressed differently. Statements that contain these words should be considered carefully because they describe the Conseco's expectations, plans, strategies and goals and the Conseco's beliefs concerning future business conditions, the Conseco's results of operations, financial position, and the Conseco's business outlook or they state other "forward-looking" information based on currently available information. The "Risk Factors" section of Conseco's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q provides examples of risks, uncertainties and events that could cause the Conseco's actual results to differ materially from the expectations expressed in forward-looking statements. All written or oral forward-looking statements attributable to Conseco are expressly qualified in their entirety by the foregoing cautionary statement. The forward-looking statements speak only as of the date made. Conseco assumes no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.

    Conseco, Inc.

    CONTACT: News Media: Tony Zehnder, Corporate Communications
    +1-312-396-7086, or for Investors, Scott Galovic, Investor Relations
    +1-317-817-3228

    Web Site: http://www.conseco.com/




    EXFO Reports Fourth-Quarter and Year-End Results for Fiscal 2009- Annual sales decrease 5.9% in the current economic environment - Record cash flows from operations attain US$22.6 million - Gross margin improves for a seventh consecutive year to reach 61.3% - Cash position of US$69.7 million and no debt

    QUEBEC CITY, Oct. 13 /PRNewswire-FirstCall/ -- EXFO Electro-Optical Engineering Inc. reported today fourth-quarter and year-end financial results for the fiscal year ended August 31, 2009.

    Annual sales decreased 5.9% to US$172.9 million in fiscal 2009 from US$183.8 million in 2008. In the fourth quarter of 2009, sales reached US$36.5 million compared to US$43.6 million in the previous quarter and US$50.9 million in the fourth quarter of 2008. Overall for fiscal 2009, net bookings decreased 2.2% to US$180.5 million from US$184.6 million in 2008 for an annual book-to-bill ratio of 1.04. In the fourth quarter of 2009, net bookings totaled US$40.7 million for a book-to-bill ratio of 1.11 compared to US$40.2 million in the third quarter of 2009 and US$45.7 million in the fourth quarter of 2008.

    Gross margin improved for a seventh consecutive year to reach 61.3% of sales in fiscal 2009. In the fourth quarter of 2009, gross margin amounted to 60.0% compared to 62.3% in the previous quarter and 59.9% in the fourth quarter of 2008.

    In fiscal 2009, GAAP net loss totaled US$16.6 million, or US$0.27 per share, including US$21.7 million for impairment of goodwill, US$5.1 million in amortization of intangible assets, US$1.4 million in stock-based compensation costs and US$1.2 million in restructuring charges. These items were partially offset by US$1.9 million for the recognition of previously unrecognized R&D tax credits and US$0.9 million for the net recovery of income taxes. These items resulted in a net income tax recovery of US$2.6 million.

    In fiscal 2008, GAAP net earnings reached US$18.4 million, or US$0.27 per diluted share, including US$6.5 million for the net recovery of income taxes and an extraordinary gain of US$3.0 million related to the negative goodwill on the acquisition of Navtel Communications. These items were partially offset by US$3.9 million in amortization of intangible assets and US$1.3 million in stock-based compensation costs. These items resulted in a net income tax recovery of US$0.9 million.

    In the fourth quarter of 2009, GAAP net loss amounted to US$1.2 million, or US$0.02 per share, including US$1.2 million in restructuring charges, US$1.1 million in amortization of intangible assets, and US$0.4 million in stock-based compensation costs. These items were offset by US$1.9 million for the recognition of previously unrecognized R&D tax credits and US$0.9 million for the net recovery of income taxes. These items resulted in a net income tax expense of US$0.1 million.

    In the third quarter of fiscal 2009, GAAP net loss totaled US$23.3 million, or US$0.39 per share. EXFO recorded a non-cash charge of US$21.7 million for impairment of goodwill and a foreign exchange loss of US$4.7 million in the third quarter of 2009. GAAP net loss in the third quarter of 2009 also included US$1.4 million in amortization of intangible assets and US$0.4 million in stock-based compensation costs. These items resulted in a net income tax recovery of US$2.3 million.

    In the fourth quarter of 2008, GAAP net earnings amounted to US$3.3 million, or US$0.05 per diluted share, including US$1.4 million in amortization of intangible assets and US$0.4 million in stock-based compensation costs. These items resulted in a net income tax recovery of US$0.2 million.

    "EXFO made significant progress navigating through the severe global economic recession in fiscal 2009 and I believe we continued to gain market share from a reduced telecom test and service assurance pie," said Germain Lamonde, EXFO's Chairman, President and CEO. "I'm particularly pleased with our Protocol business which grew 63.1% on full-year revenue contributions from the Brix and Navtel acquisitions and on our focus on IP convergence - both in fixed and mobile communication networks - to account for more than one-third of Telecom revenues. We also continued building for the future in key telecom growth sectors with 26 new product introductions, including several game-changing solutions."

    "It was more challenging on the EBITDA side, given lower sales volume caused by the recession, but actions were taken to align our operating expenses to market conditions through a US$6 million annualized cost-reduction plan in the fourth quarter," Mr. Lamonde added. "I'm pleased we still raised our gross margin for a seventh consecutive year to reach 61.3%, generated record cash flows from operations of US$22.6 million, and maintained a healthy balance sheet. Now that the worst of the economic recession seems to be behind us, I'm excited about EXFO's strong strategic position to take advantage of key market opportunities and return to our profitable growth path, as reflected in our new corporate performance metrics for the next three years."

    Selected Financial Information (In thousands of US dollars) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Segmented Q4 2009 Q3 2009 Q4 2008 FY 2009 FY 2008 results: ----------- ----------- ----------- ----------- ------------ (unaudited) (unaudited) (unaudited) (unaudited) Sales: Telecom Division $ 31,509 $ 39,047 $ 45,338 $ 153,082 $ 160,981 Life Sciences & Indus- trial Division 4,998 4,589 5,605 19,796 22,809 ----------- ----------- ----------- ----------- ------------ Total $ 36,507 $ 43,636 $ 50,943 $ 172,878 $ 183,790 ----------- ----------- ----------- ----------- ------------ ----------- ----------- ----------- ----------- ------------ Earnings (loss) from operations: Telecom Division $ (3,238) $ (21,990) $ 2,867 $ (21,954) $ 9,524 Life Sciences & Indus- trial Division 2,020 438 721 3,876 2,459 ----------- ----------- ----------- ----------- ------------ Total $ (1,218) $ (21,552) $ 3,588 $ (18,078) $ 11,983 ----------- ----------- ----------- ----------- ------------ ----------- ----------- ----------- ----------- ------------ Other selected information: GAAP net earnings (loss) $ (1,181) $ (23,346) $ 3,314 $ (16,585) $ 18,424 Recognition of pre- viously unrecognized R&D tax credits $ (1,902) $ - $ - $ (1,902) $ - Amortiza- tion of intangible assets $ 1,147 $ 1,355 $ 1,402 $ 5,067 $ 3,871 Restruc- turing charges $ 1,171 $ - $ - $ 1,171 $ - Impairment of goodwill $ - $ 21,713 $ - $ 21,713 $ - Stock- based compensa- tion costs $ 379 $ 383 $ 368 $ 1,409 $ 1,272 Net recovery of income tax $ (943) $ - $ - $ (943) $ (6,515) Extraor- dinary gain (negative goodwill) $ - $ - $ - $ - $ (3,036) Net income tax effect of the above items $ 93 $ (2,273) $ (225) $ (2,613) $ (915) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Operating Expenses

    Selling and administrative expenses amounted to US$63.8 million, or 36.9% of sales, in fiscal 2009 compared to US$61.2 million, or 33.3% of sales, in 2008. In the fourth quarter of 2009, selling and administrative expenses totaled US$14.2 million, or 38.9% of sales, compared to US$16.7 million, or 38.3% of sales, in the third quarter of 2009 and US$17.0 million, or 33.4% of sales, in the fourth quarter of 2008.

    Gross research and development (R&D) expenses reached US$35.8 million, or 20.7% of sales, in fiscal 2009 compared to US$32.5 million, or 17.7% of sales, in 2008. In the fourth quarter of 2009, gross R&D expenses attained US$9.0 million, or 24.7% of sales, compared to US$9.3 million, or 21.4% of sales, in the previous quarter and US$8.6 million, or 16.8% of sales, in the fourth quarter of 2008.

    Net R&D expenses totaled US$27.7 million, or 16.0% of sales in fiscal 2009, compared to US$26.9 million, or 14.6% of sales, in 2008. In the fourth quarter of 2009, net R&D expenses amounted to US$5.4 million, or 14.7% of sales, compared to US$7.8 million, or 17.8% of sales, in the third quarter of 2009 and US$7.3 million, or 14.3% of sales, in the fourth quarter of 2008.

    Fiscal 2009 Business Highlights - Market expansion - EXFO's annual sales decreased 5.9%, or 13.5% on an organic basis (excluding acquisitions and gains or losses from forward exchange contracts recorded in sales), largely due to the global economic recession in 2009. Protocol sales, benefiting from full-year revenue contributions from the Brix Networks and Navtel Communications acquisitions, IP convergence and network capacity upgrades on wireline and wireless networks, increased 63.1% year-over-year. The company's Optical (-17.5%) and Copper Access (-21.8%) businesses were more affected by challenging market conditions, since many network operators deferred capital-intensive deployment decisions. Likewise, the Life Sciences and Industrial Division (-13.2%) was affected by difficult market conditions. In terms of geographic diversification, the Americas accounted for 57.4% of sales in 2009 (vs. 55.8% in 2008), Europe, Middle East and Africa (EMEA) 26.9% (vs. 28.4% in 2008), and Asia- Pacific 15.7% (vs. 15.8% in 2008). EXFO's largest customer accounted for 11.6% of total sales, while the company's top three customers represented 17.8%. - Profitability -EXFO raised its gross margin for a seventh consecutive year to reach 61.3%, generated a record of US$22.6 million in cash flows from operations, and closed fiscal 2009 with a cash position of US$69.7 million and no debt. EBITDA dropped to US$14.5 million, or 8.4% of sales, mainly due to the global economic recession. The company implemented a restructuring plan in the fourth quarter that incurred a charge of US$1.2 million but will provide US$6 million in annualized cost savings. - Innovation - EXFO launched 26 new products in fiscal 2009, including three in the fourth quarter, compared to 27 in 2008. Key product introductions in 2009 included laboratory and portable test solutions for characterizing 100 Gbit/s Ethernet and 40/43 Gbit/s SONET/OTN networks; a distributed PMD analyzer that allows network operators to cost-effectively upgrade their networks to 40 Gbit/s and 100 Gbit/s; new software releases for the IMS InterWatch platform and Packet Blazer product lines that support the migration of voice and video applications to the IPv6 (Internet Protocol, version 6) addressing scheme; and the next-generation FTB-500 multi-layer platform for high- end test applications in the field and central office. Following the year-end, the company released the industry's first turnkey optical modulation analyzer for complete characterization of signals up to 100 Gbaud/s. Sales from products on the market two years or less accounted for 38.4% of total sales in fiscal 2009, including 38.8% in the fourth quarter, compared to 34.6% in fiscal 2008. Business Outlook

    EXFO forecasted sales between US$40 million and US$45 million and a GAAP net loss between US$0.06 and US$0.02 per share for the first quarter of 2010. GAAP net loss includes US$0.02 per share in after-tax amortization of intangible assets and stock-based compensation costs and assumes a pre-tax foreign exchange loss of US$0.03 per share to account for the significant decrease of the US dollar compared to the Canadian dollars since the end of the fourth quarter of fiscal 2009.

    This guidance was established by management based on existing backlog as of the date of this press release, seasonality and expected bookings for the remaining of the quarter.

    Corporate Performance Objectives for Fiscal 2010-2012

    Given the global economic recession in fiscal 2009, EXFO has adjusted its corporate performance metrics over a new three-year period extending from fiscal 2010 to 2012. The company has maintained its 20% sales CAGR objective, proposed to double EBITDA in dollars, and raised its gross margin target to 64% for the newly defined three-year period.

    ------------------------------------------------------ Corporate Performance Objectives for FY 2010-2012 ------------------------------------------------------ Increase sales by a CAGR of 20% or more ------------------------------------------------------ Raise gross margin to 64% ------------------------------------------------------ Double EBITDA* in dollars ------------------------------------------------------ * EBITDA is defined as net earnings (loss) before interest, income taxes, amortization of property, plant and equipment, amortization of intangible assets, impairment of goodwill and extraordinary gain. See the following page on EXFO's Website, http://www.exfo.com/investors, for a reconciliation with GAAP net earnings (loss) in previous fiscal years. Conference Call and Webcast

    EXFO will host a conference call today at 5 p.m. (Eastern time) to review its fourth-quarter and year-end financial results for fiscal 2009. To listen to the conference call and participate in the question period via telephone, dial 1-416-641-6654. Germain Lamonde, Chairman, President and CEO, and Pierre Plamondon, CA, Vice-President of Finance and Chief Financial Officer, will participate in the call. An audio replay will be available one hour after the end of the conference call until 7 p.m. on October 20, 2009. The replay number is 1-402-977-9141 and the reservation number is 21434695. The live audio Webcast and replay of the conference call will also be available on EXFO's Website at http://www.exfo.com/investors.

    About EXFO

    EXFO is a leading provider of test and service assurance solutions for network service providers and equipment manufacturers in the global telecommunications industry. The Telecom Division offers a wide range of innovative solutions extending across the full technology lifecycle ? from design to technology deployment and onto service assurance ? and covering all layers on a network infrastructure to enable triple-play services and next-generation, converged IP networking. The Life Sciences and Industrial Division offers solutions in medical device and opto-electronics assembly, fluorescence microscopy and other life science sectors. For more information, visit http://www.exfo.com/.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, and we intend that such forward-looking statements be subject to the safe harbors created thereby. Forward-looking statements are statements other than historical information or statements of current condition. Words such as may, will, expect, believe, anticipate, intend, could, estimate, continue, or the negative or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections or other characterizations of future events and circumstances are considered forward-looking statements. They are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those in forward-looking statements due to various factors including the effect of the worldwide recession and the timing of the expected recovery on the telecom market for our customers and suppliers; fluctuating exchange rates and our ability to execute in these uncertain conditions; consolidation in the global telecommunications test, measurement and service assurance industry; capital spending levels in the telecommunications, life sciences and high-precision assembly sectors; concentration of sales; the effects of the additional actions we have taken in response to such economic uncertainty (including our ability to quickly adapt cost structures with anticipated levels of business, ability to manage inventory levels with market demand); market acceptance of our new products and other upcoming products; limited visibility with regards to customer orders and the timing of such orders; our ability to successfully integrate our acquired and to-be-acquired businesses; our ability to successfully expand international operations; the retention of key technical and management personnel; and future economic, competitive, financial and market condition .Assumptions relating to the foregoing involve judgments and risks, all of which are difficult or impossible to predict and many of which are beyond our control. Other risk factors that may affect our future performance and operations are detailed in our Annual Report, on Form 20-F, and our other filings with the U.S. Securities and Exchange Commission and the Canadian securities commissions. We believe that the expectations reflected in the forward-looking statements are reasonable based on information currently available to us, but we cannot assure you that the expectations will prove to have been correct. Accordingly, you should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this document. Unless required by law or applicable regulations, we undertake no obligation to revise or update any of them to reflect events or circumstances that occur after the date of this document.

    EXFO Electro-Optical Engineering Inc. Interim Consolidated Balance Sheet (in thousands of US dollars) As at August 31, ------------------------ 2009 2008 ----------- ----------- Assets (unaudited) Current assets Cash $ 10,611 $ 5,914 Short-term investments 59,105 81,626 Accounts receivable Trade 22,946 31,473 Other 2,752 4,753 Income taxes and tax credits recoverable 2,353 4,836 Inventories 30,863 34,880 Prepaid expenses 2,043 1,774 Future income taxes 5,538 9,140 ----------- ----------- 136,211 174,396 Tax credits recoverable 26,762 20,657 Forward exchange contracts 428 - Property, plant and equipment 19,100 19,875 Intangible assets 16,859 19,945 Goodwill 22,478 42,653 Future income taxes 18,533 15,540 ----------- ----------- $ 240,371 $ 293,066 ----------- ----------- ----------- ----------- Liabilities Current liabilities Accounts payable and accrued liabilities $ 21,650 $ 24,713 Deferred revenue 6,481 5,079 ----------- ----------- 28,131 29,792 Deferred revenue 4,195 3,759 ----------- ----------- 32,326 33,551 ----------- ----------- Shareholders' equity Share capital 104,846 142,786 Contributed surplus 17,758 5,226 Retained earnings 43,909 60,494 Accumulated other comprehensive income 41,532 51,009 ----------- ----------- 208,045 259,515 ----------- ----------- $ 240,371 $ 293,066 ----------- ----------- ----------- ----------- EXFO Electro-Optical Engineering Inc. Interim Unaudited Consolidated Statements of Earnings (in thousands of US dollars, except share and per share data) Three Twelve Three Twelve months months months months ended ended ended ended August 31, August 31, August 31, August 31, 2009 2009 2008 2008 ----------- ----------- ----------- ----------- Sales $ 36,507 $ 172,878 $ 50,943 $ 183,790 Cost of sales(1),(2) 14,618 66,892 20,416 75,624 ----------- ----------- ----------- ----------- Gross margin 21,889 105,986 30,527 108,166 ----------- ----------- ----------- ----------- Operating expenses Selling and administrative(1) 14,185 63,808 16,993 61,153 Net research and development(1),(3) 5,371 27,698 7,297 26,867 Amortization of property, plant and equipment 1,233 4,607 1,247 4,292 Amortization of intangible assets 1,147 5,067 1,402 3,871 Restructuring charges 1,171 1,171 - - Impairment of goodwill - 21,713 - - ----------- ----------- ----------- ----------- Total operating expenses 23,107 124,064 26,939 96,183 ----------- ----------- ----------- ----------- Earnings (loss) from operations (1,218) (18,078) 3,588 11,983 Interest income (expense) (86) 597 576 4,639 Foreign exchange gain 186 1,157 1,349 442 ----------- ----------- ----------- ----------- Earnings (loss) before income taxes and extraordinary gain (1,118) (16,324) 5,513 17,064 Income taxes Current 413 561 (14) (7,094) Future 22 72 2,213 14,094 Recognition of previously unrecognized future income tax assets (372) (372) - (5,324) ----------- ----------- ----------- ----------- 63 261 2,199 1,676 ----------- ----------- ----------- ----------- Earnings (loss) before extraordinary gain (1,181) (16,585) 3,314 15,388 Extraordinary gain - - - 3,036 ----------- ----------- ----------- ----------- Net earnings (loss) for the period $ (1,181) $ (16,585) $ 3,314 $ 18,424 ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- Basic and diluted earnings (loss) before extraordinary gain per share $ (0.02) $ (0.27) $ 0.05 $ 0.22 Basic and diluted net earnings (loss) per share $ (0.02) $ (0.27) $ 0.05 $ 0.27 Basic weighted average number of shares outstanding (000's) 59,553 61,845 68,082 68,767 Diluted weighted average number of shares outstanding (000's) 59,553 61,845 68,550 69,318 (1) Stock-based compensation costs included in: Cost of sales $ 40 $ 137 $ 36 $ 148 Selling and administrative 221 858 232 830 Net research and development 118 414 100 294 ----------- ----------- ----------- ----------- $ 379 $ 1,409 $ 368 $ 1,272 ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- (2) The cost of sales is exclusive of amortization, shown separately. (3) Net research and development expenses for the three and twelve months ended August 31, 2009 include recognition of previously unrecognized research and development tax credits of $1,902. EXFO Electro-Optical Engineering Inc. Interim Unaudited Consolidated Statements of Comprehensive Income (Loss) And Accumulated Other Comprehensive Income (in thousands of US dollars) Comprehensive income (loss) Three Twelve Three Twelve months months months months ended ended ended ended August 31, August 31, August 31, August 31, 2009 2009 2008 2008 ----------- ----------- ----------- ----------- Net earnings (loss) for the period $ (1,181) $ (16,585) $ 3,314 $ 18,424 Foreign currency translation adjustment (1,078) (10,671) (18,511) (2,289) Changes in unrealized gains (losses) on short-term investments - 22 (9) 31 Unrealized gains (losses) on forward exchange contracts (229) (1,467) (1,882) 962 Reclassification of realized gains (losses) on forward exchange contracts in net earnings (loss) 84 3,167 (770) (3,915) Future income taxes effect of the above items 44 (528) 822 909 ----------- ----------- ----------- ----------- Comprehensive income (loss) $ (2,360) $ (26,062) $ (17,036) $ 14,122 ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- Accumulated other comprehensive income Twelve months ended August 31, ------------------------ 2009 2008 ----------- ----------- Foreign currency translation adjustment Cumulative effect of prior periods $ 51,129 $ 53,418 Current period (10,671) (2,289) ----------- ----------- 40,458 51,129 ----------- ----------- Unrealized gains (losses) on forward exchange contracts Cumulative effect of prior periods (96) 1,948 Current period, net of realized gains and future income taxes 1,172 (2,044) ----------- ----------- 1,076 (96) ----------- ----------- Unrealized gains (losses) on short-term investments Cumulative effect of prior periods (24) (55) Current period, net of future income taxes 22 31 ----------- ----------- (2) (24) ----------- ----------- Accumulated other comprehensive income $ 41,532 $ 51,009 ----------- ----------- ----------- ----------- EXFO Electro-Optical Engineering Inc. Interim Unaudited Consolidated Statements of Retained Earnings and Contributed Surplus (in thousands of US dollars) Retained earnings Twelve months ended August 31, ------------------------ 2009 2008 ----------- ----------- Balance - Beginning of period $ 60,494 $ 42,330 Add (deduct) Net earnings (loss) for the period (16,585) 18,424 Premium on redemption of share capital - (260) ----------- ----------- Balance - End of period $ 43,909 $ 60,494 ----------- ----------- ----------- ----------- Contributed surplus Twelve months ended August 31, ------------------------ 2009 2008 ----------- ----------- Balance - Beginning of period $ 5,226 $ 4,453 Add (deduct) Stock-based compensation costs 1,407 1,287 Reclassification of stock-based compensation costs to share capital upon exercise of stock awards (540) (514) Discount on redemption of share capital 11,665 - ----------- ----------- Balance - End of period $ 17,758 $ 5,226 ----------- ----------- ----------- ----------- EXFO Electro-Optical Engineering Inc. Interim Unaudited Consolidated Statements of Cash Flows (in thousands of US dollars) Three Twelve Three Twelve months months months months ended ended ended ended August 31, August 31, August 31, August 31, 2009 2009 2008 2008 ----------- ----------- ----------- ----------- Cash flows from operating activities Net earnings (loss) for the period $ (1,181) $ (16,585) $ 3,314 $ 18,424 Add (deduct) items not affecting cash Change in discount on short-term investments 24 597 (486) 1,035 Stock-based compensation costs 379 1,409 368 1,272 Amortization 2,380 9,674 2,649 8,163 Deferred revenue (1,539) 1,706 482 47 Loss on disposal of capital assets - 237 - - Impairment of goodwill - 21,713 - - Future income taxes (350) (300) 2,213 8,770 Extraordinary gain - - - (3,036) Change in unrealized foreign exchange loss (gain) (414) (1,955) (1,619) (1,093) ----------- ----------- ----------- ----------- (701) 16,496 6,921 33,582 Change in non-cash operating items Accounts receivable 9,015 9,654 (4,193) (4,338) Income taxes and tax credits (1,202) (3,391) (1,396) (12,833) Inventories 1,935 2,624 712 (2,166) Prepaid expenses (12) (350) 379 (127) Accounts payable and accrued liabilities (1,870) (2,409) 1,659 (1,416) ----------- ----------- ----------- ----------- 7,165 22,624 4,082 12,702 ----------- ----------- ----------- ----------- Cash flows from investing activities Additions to short-term investments (88,561) (438,460) (72,800) (717,020) Proceeds from disposal and maturity of short-term investments 82,570 456,612 73,939 760,310 Additions to capital assets (978) (6,945) (1,452) (6,508) Business combinations, net of cash acquired - (2,414) (78) (41,016) ----------- ----------- ----------- ----------- (6,969) 8,793 (391) (4,234) ----------- ----------- ----------- ----------- Cash flows from financing activities Change in bank loan - - (1,485) - Redemption of share capital (793) (26,871) (4,675) (8,068) Exercise of stock options 15 56 - 61 ----------- ----------- ----------- ----------- (778) (26,815) (6,160) (8,007) ----------- ----------- ----------- ----------- Effect of foreign exchange rate changes on cash 110 95 (199) (88) Change in cash (472) 4,697 (2,668) 373 Cash - Beginning of period 11,083 5,914 8,582 5,541 ----------- ----------- ----------- ----------- Cash - End of period $ 10,611 $ 10,611 $ 5,914 $ 5,914 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------

    EXFO ELECTRO-OPTICAL ENGINEERING INC.

    CONTACT: Vance Oliver, Manager, Investor Relations, (418) 683-0913, Ext.
    3733, vance.oliver@exfo.com




    CSX Announces Third Quarter Earnings

    JACKSONVILLE, Fla., Oct. 13 /PRNewswire-FirstCall/ --

    Third Quarter Highlights: -- Earnings per share of 74 cents and operating income of $598 million -- Operating ratio of 73.9 percent, a third quarter record -- Strong safety and service performance

    CSX Corporation today announced third quarter earnings from continuing operations of $293 million, or 74 cents a share, versus $380 million, or 93 cents a share, in the same period last year.

    Third quarter revenues of $2.3 billion were down 23 percent from the prior year, primarily due to a 15 percent decline in volume and lower fuel surcharge recovery. At the same time, core pricing remained strong and consistent with prior quarters, reflecting high service levels and the overall value of rail transportation. While volumes declined across the business, the rate of decline continued to slow in nearly all markets compared to the second quarter.

    "The third quarter reinforces our view that the worst of the recession is likely behind us," said Michael J. Ward, chairman, president and chief executive officer. "At the same time, our coal business will be impacted by weak demand well into 2010."

    CSX continued to improve its network efficiency and safety while reducing operating costs by 24 percent compared to the same period last year. As a result of these efforts and a sustained focus on yield management, CSX produced operating income of $598 million and a third quarter record operating ratio of 73.9 percent.

    "The CSX team is clearly demonstrating that it can achieve excellence in any environment," said Ward. "As the economy regains strength, we are emerging as a stronger, leaner company in an industry that is positioned to grow over the long term."

    CSX Corporation, based in Jacksonville, Fla., is a leading transportation company providing rail, intermodal and rail-to-truck transload services. The company's transportation network spans approximately 21,000 miles with service to 23 eastern states and the District of Columbia, and connects to more than 70 ocean, river and lake ports.

    This earnings announcement, as well as a package of detailed financial information, is contained in the CSX Quarterly Financial Report available on the company's website at http://investors.csx.com/ in the Investors section and on Form 8-K with the Securities and Exchange Commission ("SEC").

    CSX executives will conduct a quarterly earnings conference call with the investment community on October 14, 2009 at 8:30 a.m. ET. Investors, media and the public may listen to the conference call by dialing 888-327-6279 (888-EARN-CSX) and asking for the CSX earnings call. (Callers outside the U.S., dial 773-756-0199). Participants should dial in 10 minutes prior to the call. In conjunction with the call, a live webcast will be accessible and presentation materials will be posted on the company's website at http://investors.csx.com/. Following the earnings call, an internet replay of the presentation will be archived on the company website.

    Forward-looking statements

    This information and other statements by the company contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to, among other items: projections and estimates of earnings, revenues, cost-savings, expenses, or other financial items; statements of management's plans, strategies and objectives for future operation, and management's expectations as to future performance and operations and the time by which objectives will be achieved; statements concerning proposed new products and services; and statements regarding future economic, industry or market conditions or performance. Forward-looking statements are typically identified by words or phrases such as "believe," "expect," "anticipate," "project," "estimate," "preliminary" and similar expressions. Forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update or revise any forward-looking statement. If the company does update any forward-looking statement, no inference should be drawn that the company will make additional updates with respect to that statement or any other forward-looking statements.

    Forward-looking statements are subject to a number of risks and uncertainties, and actual performance or results could differ materially from that anticipated by these forward-looking statements. Factors that may cause actual results to differ materially from those contemplated by these forward-looking statements include, among others; (i) the company's success in implementing its financial and operational initiatives; (ii) changes in domestic or international economic or business conditions, including those affecting the rail industry (such as the impact of industry competition, conditions, performance and consolidation); (iii) legislative or regulatory changes; (iv) the inherent business risks associated with safety and security; and (v) the outcome of claims and litigation involving or affecting the company.

    Other important assumptions and factors that could cause actual results to differ materially from those in the forward-looking statements are specified in the company's SEC reports, accessible on the SEC's website at http://www.sec.gov/ and the company's website at http://www.csx.com/.

    CSX Corporation

    CONTACT: David Baggs, Investor Relations, +1-904-359-4812, or Garrick
    Francis, Corporate Communications, +1-877-835-5279

    Web Site: http://www.csx.com/




    Sealy to Present at the Wells Fargo Consumer Conference

    TRINITY, N.C., Oct. 13 /PRNewswire-FirstCall/ -- Sealy Corporation , the largest bedding manufacturer in the world, announced today that the Company will be presenting at the 2009 Wells Fargo Consumer Conference on Wednesday, October 28, 2009 at the Palace Hotel in New York City, NY. The presentation will begin at 9:00 AM Eastern time. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investors section of the Company's website at http://www.sealy.com/. The on-line replay will be available immediately following the presentation until 60 days post-conference.

    About Sealy

    Sealy is the largest bedding manufacturer in the world with sales of $1.5 billion in fiscal 2008. The Company manufactures and markets a broad range of mattresses and foundations under the Sealy(R), Sealy Posturepedic(R), including SpringFree(TM), PurEmbrace(TM) and TrueForm(R); Stearns & Foster(R), and Bassett(R) brands. Sealy operates 25 plants in North America, and has the largest market share and highest consumer awareness of any bedding brand on the continent. In the United States, Sealy sells its products to approximately 3,000 customers with more than 7,000 retail outlets. Sealy is also a leading supplier to the hospitality industry. For more information, please visit http://www.sealy.com/.

    This document contains forward-looking statements within the meaning of the safe harbor provisions of the Securities Litigation Reform Act of 1995. Terms such as "expect," "believe," "continue," and "grow," as well as similar comments, are forward-looking in nature. Although the Company believes its growth plans are based upon reasonable assumptions, it can give no assurances that such expectations can be attained. Factors that could cause actual results to differ materially from the Company's expectations include: general business and economic conditions, competitive factors, raw materials purchasing, and fluctuations in demand. Please refer to the Company's Securities and Exchange Commission filings for further information.

    Sealy Corporation

    CONTACT: Mark D. Boehmer, VP & Treasurer, Sealy Corporation,
    +1-336-862-8705

    Web Site: http://www.sealy.com/




    AirTran Airways and the Atlanta Falcons Launch Falcons 1- Custom Painted Boeing 717 Makes its Debut -

    ATLANTA, Oct. 13 /PRNewswire-FirstCall/ -- AirTran Airways, a subsidiary of AirTran Holdings, Inc. , and the Atlanta Falcons today launched a one-of-a-kind, custom-painted Boeing 717 in Falcons colors. The plane, dubbed Falcons 1, will operate across the company's network of more than 60 destinations.

    (Photo: http://www.newscom.com/cgi-bin/prnh/20091013/NY91830 )

    Falcons 1 marks the first time in the company's history that an aircraft has been co-branded from nose to tail.

    "There's no better way to celebrate our partnership than to launch the best looking airplane in the sky," said Tad Hutcheson, AirTran Airways' vice president of marketing and sales. "Falcons 1 will serve millions of passengers and act as a constant reminder of our winning team, the Falcons and AirTran."

    The partnership, announced in September, includes joint promotions, prominent signage at the Georgia Dome and billboards and other advertising featuring Falcon players in full uniform in addition to Falcons 1.

    "What an awesome privilege it is to have such a great looking airplane flying around the country in our honor," said Jim Smith, Atlanta Falcons vice president of marketing. "We are so pleased to know that passengers everywhere will see the Falcons and AirTran logos flying side-by-side for years to come."

    To commemorate the unveiling of Falcons 1 and to mark breast cancer awareness month, members of the Atlanta Falcons cheerleaders and drumline pulled the 100,000 pound aircraft for the charity, Breast Friends, Inc. AirTran Airways responded with a $10,000 donation to the charity.

    AirTran Airways, a subsidiary of AirTran Holdings, Inc., and a Fortune 1000 company, has been ranked the number one low cost carrier in the Airline Quality Rating study for the past two years. AirTran is the only major airline with Wi-Fi on every flight and offers coast-to-coast service on North America's newest all-Boeing fleet. Its low-cost, high-quality product also includes assigned seating, Business Class and complimentary XM Satellite Radio on every flight. To book a flight, visit http://www.airtran.com/.

    Media Contacts: AirTran Airways Christopher White Cynthia Tinsley-Douglas 678.254.7442 Atlanta Falcons Brian Cearns (770) 965-4318 Matt Conti (770) 965-4350

    Photo: http://www.newscom.com/cgi-bin/prnh/20091013/NY91830
    http://photoarchive.ap.org/
    AP PhotoExpress Network: PRN19
    PRN Photo Desk, photodesk@prnewswire.com AirTran Airways

    CONTACT: Christopher White or Cynthia Tinsley-Douglas, both of AirTran
    Airways, +1-678-254-7442; or Brian Cearns, +1-770-965-4318, or Matt Conti,
    +1-770-965-4350, both of Atlanta Falcons

    Web Site: http://www.airtran.com/




    Advanced Energy to Report Third Quarter 2009 Financial Results Before Market Open

    FORT COLLINS, Colo., Oct. 13 /PRNewswire-FirstCall/ -- Advanced Energy Industries, Inc. will release third quarter 2009 financial results on Wednesday, October 28, 2009. Management's quarterly company update will also be held on October 28, 2009, beginning at 5:30 a.m. Pacific Time/ 8:30 a.m. Eastern Time.

    To participate in the live conference call, dial 888-713-4717 approximately five minutes prior to the start of the meeting, and an operator will connect you. International participants should dial 816-650-2836. Participants will need to provide the operator with conference pass code 35702731, which has been reserved for this call.

    A live and archived webcast of the call will also be available on the company's website. To access the webcast, visit the Investor Relations section of Advanced Energy's corporate website at http://ir.advanced-energy.com/, and link to the Q309 Webcast on the Investor Relations Home Page. The archived webcast will be available at the same location approximately two hours following the end of the live event.

    A telephone replay will be available for 48 hours following the webcast. To access the replay, dial 800-642-1687 or 706-645-9291 and enter conference pass code 35702731.

    About Advanced Energy

    Advanced Energy® is a global leader in innovative power and control technologies for high-growth, thin-film manufacturing and solar-power generation. Specifically, AE targets solar grid-tie inverters, solar cells, semiconductors, flat panel displays, data storage products, architectural glass and other advanced applications.

    Photo: http://www.newscom.com/cgi-bin/prnh/20030825/AEISLOGO
    http://photoarchive.ap.org/
    PRN Photo Desk, photodesk@prnewswire.com/ Advanced Energy Industries, Inc.

    CONTACT: Annie Leschin or Vanessa Lehr, both of Advanced Energy
    Industries, Inc., +1-970-407-6555, ir@aei.com

    Web Site: http://www.advanced-energy.com/




    Medifast, Inc. Announces Appointment of Three Additional Independent Board Members

    OWINGS MILLS, Md., Oct. 13 /PRNewswire-FirstCall/ -- Medifast, Inc. , a provider of leading clinically-proven portion controlled weight-loss programs, today announced the election of H.C. "Barney" Barnum, Jr., Jason L. Groves, and Jerry D. Reece, to the Medifast Board of Directors at the Medifast Annual Meeting of Shareholders held on October 9, 2009. With the addition of Mssrs. Barnum, Groves and Reece, the Medifast Board of Directors is now comprised of fourteen members, ten of which are classified as independent under the rules of the New York Stock Exchange.

    Additionally, four current members of the Medifast Board of Directors were re-elected. Barry B. Bondroff, George J. Lavin, Catherine T. Maguire and Jeannette M. Mills will hold office for a three-year period until 2012. John P. McDaniel was also elected to a one-year term. Mr. McDaniel was appointed to the Medifast Board of Directors in March 2009.

    Colonel Brad MacDonald, USMC (Ret.), chairman of the Board of Directors of Medifast, Inc., commented, "We are pleased that individuals with the experience of Barney, Jason and Jerry have agreed to join the board of Medifast. Their collective experience in business overlaid on their commitment to the service of our country will accrue to the benefit of Medifast shareholders in the years to come."

    "The addition of these highly qualified individuals to our board continues the tradition of a highly independent and diversified board of directors. Ten of our fourteen directors are classified as independent by NYSE guidelines; three are women, two are African-American, and four are under the age of 40 years. We firmly believe that this broad diversification in corporate governance will serve the best interests of all of our stakeholders - customers, employees and shareholders."

    Mr. Barnum was sworn in as the Deputy Assistant Secretary of the Navy for Reserve Affairs on July 23, 2001. In this capacity he was responsible for all matters regarding the Navy and Marine Corps Reserve including manpower, equipment, policy and budgeting. On Jan. 20, 2009, Barnum was designated Acting Assistant Secretary of the Navy for Manpower and Reserve Affairs.

    Mr. Barnum was the fourth Marine to be awarded the nation's highest honor, the Medal of Honor for valor in Vietnam. He retired from the Marine Corps in August 1989 after 27 and one-half years of service. Barnum served multiple tours as an artilleryman with both the 3rd and 2nd Marine Divisions to include two tours in Vietnam; 2nd Marine Aircraft Wing; guard officer at Marine Barracks, Pearl Harbor, and operations officer, Hawaiian Armed Forces Police; weapons instructor at the Officer Basic School; four years at Marine Corps Recruit Depot, Parris Island, as commanding officer, Headquarters Company and the 2nd Recruit Training Battalion of the Training Regiment; Chief of Current Operations, US Central Command where he planned and executed the first U.S./Jordanian joint exercise staff as the commander of U.S. Forces and twice planned and executed Operation Bright Star spread over four southwest Asian countries involving 26,000 personnel. Headquarters Marine Corps tours included: aide to the assistant commandant as a captain and deputy director Public Affairs, Director Special Projects Directorate and Military Secretary to the Commandant as a colonel. Upon retirement in 1989, Barnum served as the principal director, Drug Enforcement Policy, Office of the Secretary of Defense.

    Mr. Barnum's personal medals and decorations include: the Medal of Honor; Defense Superior Service Medal; Legion of Merit; the Bronze Star Medal with Combat "V" and gold star in lieu of a second award; Purple Heart; Meritorious Service Medal; Navy Commendation Medal; Navy Achievement Medal with Combat "V"; Combat Action Ribbon; Presidential Unit Citation; Army Presidential Unit Citation; Joint Meritorious Unit Award; Navy Unit Citation; two awards of the Meritorious Unit Citation; the Vietnamese Cross of Gallantry (silver) and the Department of the Navy Distinguished Public Service Award.

    Mr. Barnum has attended The Basic School, U.S. Army Field Artillery School, Amphibious Warfare School, U.S. Army Command and General Staff College and the U.S. Naval War College. He is the past president of the Congressional Medal of Honor Society, Connecticut Man of the Year '67, presented Honorary Legum Doctorem St. Anselm College; Rotary Paul Harris Fellow; Abe Pollin Leadership Award '03, Marine Corps League "Iron Mike" Award and Order of the Carabao Distinguished Service Award.

    Mr. Jason L. Groves is a Manager for Verizon's Public Policy and External Affairs, Federal Regulatory Division in Washington, D.C. with responsibility for Federal Communication Commission enforcement matters. Currently, he is Verizon Maryland External Affairs Assistant Vice President. Mr. Groves is a U.S. Army veteran. He was a direct commissioned Judge Advocate in the United States Army Judge Advocate General's Corps (JAG). As a JAG Officer, he practiced law while stationed at Fort George G. Meade, Maryland. He had the distinction of prosecuting criminal cases in the District Court of Maryland as a Special Assistant United States Attorney. Over the course of three years, he received two Army Achievement Medals, and one Army Commendation Medal. Mr. Groves is a graduate of the Disney University College Program for managers. He received his Bachelor of Science degree, cum laude, in Business with a concentration in Hospitality Management from Bethune-Cookman College. He also obtained his law degree from North Carolina Central University School of Law and is a member of the New Jersey and District of Columbia bars as well as several bar associations.

    Mr. Jerry D. Reece is chief executive officer of Reece & Nichols Realtors, the largest residential real estate brokerage in Greater Kansas City. With over 30 years experience in real estate, Jerry Reece formed the company in early 1987. In addition to marketing resale homes as well as a broad range of new home subdivisions, the company specializes in the corporate transferee market. After graduating from the University of Oregon in 1963 with a B.S. in Finance, Jerry Reece joined the United States Marine Corps and served in Hawaii and Vietnam as a first lieutenant. Following active duty, he continued his service in the Marine Corps Reserve. His various assignments included the command of a rifle battalion and service as a member of the Secretary of the Navy's Marine Corps Reserve Policy Board at the Pentagon. Retired with the rank of colonel, he was a member of the Board of Directors of the Marine Toys for Tots Foundation and a trustee of the Marine Corps Reserve Officers Association Foundation. His personal decorations include the Legion of Merit, The Navy Commendation Medal with Combat "V" and the Combat Action Ribbon.

    About Medifast:

    Medifast is the leading easy-to-use, clinically proven, portion-controlled weight-loss program. Medifast has been recommended by over 20,000 doctors and used by over one million customers since 1980. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) medically supervised Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.choosemedifast.com/.

    Safe Harbor Statement

    Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast believes that the expectations, statements, and assumptions reflected in these forward- looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

    MED-G Contact: Brendan Connors Lytham Partners, LLC Vice President - Finance Robert Blum ir@choosemedifast.com Joe Diaz Joe Dorame 602-889-9700

    Medifast, Inc.

    CONTACT: Brendan Connors, Vice President - Finance of Medifast, Inc.,
    ir@choosemedifast.com; or Robert Blum, Joe Diaz or Joe Dorame,
    +1-602-889-9700, all of Lytham Partners, LLC, for Medifast, Inc.

    Web Site: http://www.choosemedifast.com/




    Hillman Group Capital Trust Announces Cash Distribution on Trust Preferred Securities

    CINCINNATI, Oct. 13 /PRNewswire-FirstCall/ -- The Hillman Companies, Inc. (the "Company" or "Hillman"), - Max W. Hillman, Chief Executive Officer of The Hillman Companies, Inc. announced today that a cash distribution has been declared by Hillman Group Capital Trust for the month of October 2009 in the amount of $.241667 for each Trust Preferred Security (NYSE-Amex: HLM_P). The distribution will be payable November 2, 2009 to holders of record October 23, 2009.

    Hillman sells to hardware stores, home centers, pet suppliers, mass merchants, and other retail outlets principally in the U.S., Canada, Mexico, and South America. Their product line includes thousands of small parts such as fasteners and related hardware items, keys, key duplication systems, and identification items, such as tags, letters, numbers and signs. Services offered include design and installation of merchandising systems and maintenance of appropriate in-store inventory levels.

    For more information on the Company, please visit our website at http://www.hillmangroup.com/

    The Hillman Companies, Inc.

    CONTACT: Investor Relations, +1-513-851-4900, ext. 2084

    Web Site: http://www.hillmangroup.com/




    Anixter International Announces Third Quarter 2009 Earnings Conference Call

    GLENVIEW, Ill., Oct. 13 /PRNewswire-FirstCall/ -- Anixter International Inc. , a leading global distributor of communication products, electrical and electronic wire & cable, fasteners and other small parts, today announced that it will report final results for the third quarter 2009 on Tuesday, October 27, 2009, and broadcast a conference call to discuss these results at 9:30 am central time.

    The call will be Webcast by CCBN and can be accessed at Anixter's Website at http://www.anixter.com/webcasts. The Webcast also will be available over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at http://www.companyboardroom.com/, or by visiting any of the investor sites in CCBN's Individual Investor Network (such as America Online's Personal Finance Channel and Fidelity.com). Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (http://www.streetevents.com/). The Webcast will be archived on all of these sites for 30 days.

    About Anixter

    Anixter International is a leading global distributor of communications products, electrical and electronic wire and cable, fasteners and other small parts. The company adds value to the distribution process by providing its customers access to 1) innovative inventory management programs; 2) more than 425,000 products and over $950 million in inventory; 3) 232 warehouses with more than 6.5 million square feet of space; and 4) locations in 270 cities in 52 countries. Founded in 1957 and headquartered near Chicago, Anixter trades on The New York Stock Exchange under the symbol AXE.

    Additional information about Anixter is available on the Internet at http://www.anixter.com/

    Anixter International Inc.

    CONTACT: Dennis Letham, Chief Financial Officer of Anixter International
    Inc., +1-224-521-8601; or Investors, Chris Kettmann, +1-312-553-6716, for
    Anixter International Inc.

    Web Site: http://www.anixter.com/
    http://www.streetevents.com/




    Nanophase Technologies Announces Third Quarter 2009 Financial Conference Call

    ROMEOVILLE, Ill., Oct. 13 /PRNewswire-FirstCall/ -- Nanophase Technologies Corporation , a technology leader in nanomaterials and advanced nanoengineered products, today announced the Company will disseminate a financial news release for the third quarter of 2009 on October 28, 2009, at 3:00 p.m. CDT, 4:00 p.m. EDT. The news release will be followed by the quarter end financial conference call at 4:00 p.m. CDT, 5:00 p.m. EDT.

    Third Quarter 2009 Conference Call

    The Nanophase conference call, to be hosted by Mr. Jess Jankowski, the Company's President & CEO, is scheduled for October 28, 2009, at 4:00 p.m. CDT, 5:00 p.m. EDT. The conference call dial-in number for U.S. callers is 800-344-8034 and for international callers is 785-830-1990. The conference ID is 7NANOPHASE. Please dial in to the conference at least five minutes before the call is scheduled to begin.

    The call may be accessed through the company's website, http://www.nanophase.com/, by clicking on the link under News Center and Calendar of Events. If you are unable to attend, an audio replay will be available through November 4, 2009, by dialing either 800-283-4593 or 402-220-0872, or by logging onto the company's website and following the above directions.

    About Nanophase Technologies

    Nanophase Technologies Corporation (NANX), http://www.nanophase.com/, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media.

    This press release contains words such as "expects," "shall," "will," , "believes," and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company's current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company's results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risk and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company's dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company's nanocrystalline materials; the Company's manufacturing capacity and product mix flexibility in light of customer demand; the Company's limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company's dependence on patents and protection of proprietary information; and the resolution of litigation in which the Company may become involved. In addition, the Company's forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

    Nanophase Technologies Corporation

    CONTACT: Nancy Baldwin, Investor Relations of Nanophase Technologies
    Corporation, +1-630-771-6708

    Web Site: http://www.nanophase.com/




    Telephone access available for Inmet Mining third quarter conference call

    TORONTO, Oct. 13 /PRNewswire-FirstCall/ -- Inmet Mining Corporation (IMN-TSX) will be releasing its third quarter results on Tuesday, October 27, 2009 and then will conduct a live audio webcast of its conference call discussing those results on Wednesday, October 28, 2009 at 8:30 a.m. Eastern Time. The call will be hosted by Richard Ross, Chairman and Chief Executive Officer.

    You are cordially invited to listen to the audio webcast through either: http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2837120 or http://www.inmetmining.com/. After the broadcast, an archive of the webcast will be available on both websites.

    Interested persons who are unable to connect to the webcast can listen to the conference call by dialing +1 416-644-3421 (local/international) or toll-free +1 866-250-4877 (North America only).

    For your information a conference replay will be available beginning Wednesday, October 28, 2009 at 10:30 a.m. Eastern Time and will run until Wednesday, November 4, 2009 at midnight Eastern Time. The dial-in numbers for the replay are +1 416-640-1917 (local/international) or toll-free +1 877-289-8525 (North America only). Each dial-in number is to be followed by passcode: 4171149 followed by the number sign.

    About Inmet - Inmet is a Canadian-based global mining company that produces copper, zinc and gold. We have interests in five mining operations in locations around the world: Cayeli, Las Cruces, Pyhasalmi, Troilus and Ok Tedi. We also have a 100 percent interest in Cobre Panama, a development property in Panama.

    This press release is also available at http://www.inmetmining.com/

    Inmet Mining Corporation

    CONTACT: Lynda Beesley, Assistant Corporate Secretary, (416) 860-3968




    Infosys Honored With Oracle Titan Partner Award at Oracle(R) OpenWorld 2009Recognized for Co-Developing Price Protection Solution with Oracle

    BANGALORE, India, Oct. 13 /PRNewswire-FirstCall/ -- Infosys Technologies Limited today announced that it has been named a winner of a North America Oracle Titan Award during Oracle® OpenWorld 2009. Oracle has recognized their leading partners for outstanding solutions and business practices developed or delivered in fiscal year 2009.

    "We are honored to be recognized by Oracle as a Titan Award winner and proud to receive this award for our successful implementation with a leading global high tech distributor," said Chandrashekar Kakal, Senior Vice President and Global Head, Enterprise Solutions, Infosys. "This award reflects our strong relationship with Oracle, our deep knowledge of their solutions and Oracle's trust in Infosys to consistently deliver the highest quality of service to our mutual customers."

    Since the beginning of the relationship, Infosys and Oracle have been dedicated to high quality joint solutions. Infosys' successful implementation of the Oracle Price-Protection solution has earned it the Titan Partner Award. The solution allows manufacturers and distributors across industries to automate and control multiple business processes that are essential to creating and executing price protection transactions. Customers are seeing the benefits of these solutions, which enable higher profitability margins, greater accuracy in inventory calculation and increased efficiency and productivity.

    Infosys' end-to-end solutions span the automotive, energy, aerospace, banking, communications, healthcare, high tech, manufacturing and retail industries. The solutions Infosys offers, along with Oracle's extensive product suite, provide clients with the ability to solve their most critical problems and transform the core of their business. With a force of more than 21,000 Oracle consultants and more than 10,000 certifications, Infosys has helped set up more than 20 Centers of Excellence (COE) showcasing Oracle technologies. The services Infosys provides through these COEs range from package evaluation, package assurance, enterprise risk management, global rollouts and implementation.

    "Infosys continues to be an important partner of ours across multiple geographies and vertical markets delivering successful implementations to our joint customers," said Tyler Prince, Group Vice President, Oracle North America Applications and Public Sector Channel Sales.

    Infosys is an Oracle Certified Advantage Partner under the Oracle Partner Network. As a Diamond Sponsor of Oracle OpenWorld this year, Infosys' CEO, S. Gopalakrishnan, will be keynoting at Oracle OpenWorld on Wednesday, October 14 at 2:00 pm PT, addressing the 'Seven Game Changing Trends' that are dominating the current macro-environment and strategies for companies to increase competitiveness.

    For more information about the Infosys and Oracle partnership offerings please visit: http://www.infosys.com/oracle/offerings/default.asp

    For more information on Infosys' participation at Oracle OpenWorld 2009, please visit: http://www.infosys.com/oracle/oracle-openworld-california09/default.asp

    For more information about Infosys keynoting at Oracle OpenWorld please visit: http://www.oracle.com/us/openworld/018079.htm#wednesday

    About Infosys Technologies Limited

    Infosys defines, designs and delivers IT-enabled business solutions that help Global 2000 companies win in a Flat World. These solutions focus on providing strategic differentiation and operational superiority to clients. With Infosys, clients are assured of a transparent business partner, world-class processes, speed of execution and the power to stretch their IT budget by leveraging the Global Delivery Model that Infosys pioneered. Infosys has over 105,000 employees in over 50 offices worldwide. Infosys is part of the NASDAQ-100 Index and The Global Dow. For more information, visit http://www.infosys.com/.

    About Oracle PartnerNetwork

    Oracle PartnerNetwork is a global business network of more than 21,000 companies who deliver innovative software solutions based on Oracle software. Through access to Oracle's premier products, education, technical services, marketing and sales support, the Oracle PartnerNetwork program provides partners with the resources they need to be successful in today's global economy. Oracle partners are able to offer their customers leading-edge solutions backed by Oracle's position as the world's largest business software company. Partners who are able to demonstrate superior product knowledge, technical expertise and a commitment to doing business with Oracle qualify for the Certified Partner levels. http://oraclepartnernetwork.oracle.com/

    Infosys Safe Harbor

    Statements in connection with this release may include forward-looking statements within the meaning of US Securities laws intended to qualify for the "safe harbor" under the Private Securities Litigation Reform Act. These forward-looking statements are subject to risks and uncertainties including those described in our SEC filings available at http://www.sec.gov/ including our Annual Report on Form 20-F for the year ended March 31, 2009, and our other recent filings, and actual results may differ materially from those projected by forward-looking statements. We may make additional written and oral forward-looking statements but do not undertake, and disclaim any obligation, to update them.

    Trademarks

    Oracle is a registered trademark of Oracle Corporation and/or its affiliates.

    Infosys Technologies Limited

    CONTACT: The Americas, Peter McLaughlin of Infosys Technologies Ltd, US,
    +1-213-622-4949, Ext 206, Peter_McLaughlin@infosys.com, or Australia, Cristin
    Balog of Infosys Technologies Ltd, Australia, +61 3 9860 2277,
    Cristin_Balog@infosys.com, or Asia Pacific, Sarah Vanita Gideon of Infosys
    Technologies Ltd, India, +91 80 4156 4998, Sarah_Gideon@infosys.com, or EMEA,
    Antonia Maneta of Infosys Technologies Ltd, UK, +44 0 207 715 3499,
    Antonia_Maneta@infosys.com

    Web Site: http://www.infosys.com/




    ArvinMeritor Hosts Conference Call and Web Cast to Present Fourth-Quarter and Full-Year Earnings for Fiscal Year 2009

    TROY, Mich., Oct. 13 /PRNewswire-FirstCall/ -- ArvinMeritor, Inc. will host a telephone conference call and Web cast to discuss the company's fourth-quarter and full-year results for fiscal year 2009 on Tuesday, Nov. 10, 2009, at 9 a.m. (ET).

    To participate, call (617) 213-4837 ten minutes prior to the start of the call. Please reference participant pass code 85768695 when dialing in. Investors can also listen to the conference call in real time -- or the recorded version for 90 days afterward -- by visiting http://www.arvinmeritor.com/.

    A replay of the call will be available from Noon on Nov. 10, to 11:59 p.m. Nov. 17, 2009, by calling (888) 286-8010 (within the United States) or (617) 801-6888 for international calls. Please refer to replay pass code number 45056962.

    The company's fourth-quarter and full-year financial results will be released prior to the conference call and Web cast. The news release will be issued through PR Newswire and First Call, and will be available on the company's Web site.

    To access the listen-only audio Web cast, visit the ArvinMeritor Web site at http://www.arvinmeritor.com/ and select the Web cast link from the home page or the investor page.

    About ArvinMeritor

    ArvinMeritor, Inc. is a premier global supplier of a broad range of integrated systems, modules and components to original equipment manufacturers and the aftermarket for the transportation and industrial sectors. The company marks its centennial anniversary in 2009, celebrating a long history of 'forward thinking.' The company serves commercial truck, trailer and specialty original equipment manufacturers and certain aftermarkets, and light vehicle manufacturers. ArvinMeritor common stock is traded on the New York Stock Exchange under the ticker symbol ARM. For more information, visit the company's Web site at: http://www.arvinmeritor.com/.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20010524/ARVINLOGO )

    Photo: http://www.newscom.com/cgi-bin/prnh/20010524/ARVINLOGO ArvinMeritor, Inc.

    CONTACT: Media Inquiries: Krista Sohm, +1-248-435-7115,
    krista.sohm@arvinmeritor.com, Investor Inquiries, Brett Penzkofer,
    +1-248-435-9426, brett.penzkofer@arvinmeritor.com

    Web Site: http://www.arvinmeritor.com/




    Graffiti Entertainment to License USA Racquetball for New Racquetball Videogame for Wii(TM)

    REDWOOD CITY, CA, Oct. 13 /PRNewswire-FirstCall/ -- Graffiti Entertainment Inc., a division of Signature Devices, Inc. (SDVI - Pink Sheets) a consumer videogame manufacturer, today announced that it has signed a license agreement with USA Racquetball, the national governing body for the sport of racquetball and for the U.S. Olympic Committee. Graffiti Entertainment will publish a USA Racquetball videogame initially for the Wii(TM) system, and shortly thereafter will roll out games for other videogame console formats.

    Graffiti Entertainment's USA Racquetball game is the first racquetball videogame to be developed for the Wii(TM) system. It is presently in development and will be available in the latter part of 2010 at retail stores where videogames are sold. Marathon Projects Ltd, the New Jersey based licensing agency for USA Racquetball, negotiated the transaction. This is the first partnership agreement to be launched under the USA Racquetball licensing program.

    Jim Hiser, Executive Director for USA Racquetball stated, "Until now, the exciting sport of racquetball has only been able to be appreciated by those who actively participate in a game at a racquetball facility. Now through our partnership with Graffiti Entertainment, the sport of racquetball will become available to everyone who plays videogames and become much more widely accessible to all. By playing the USA Racquetball videogame, adults and kids will develop a love for this fast-paced sport which should further enhance the growing trend of more racquetball players joining the sport."

    Kenneth L. Hurley, CEO of Graffiti, added "We are thrilled about translating the sport of racquetball into a videogame, especially due to its natural fit for the Wii(TM) system. The physical dynamics of racquetball present unique opportunities that are very appealing to a videogame player and we are looking forward to creating an authentic playing experience. Anyone who has ever played racquetball knows how challenging a workout and how much fun playing racquetball can be. Now they will be able to actively feel this experience in their own home."

    Craig Kalter, President of Marathon Projects, noted, "We always believed that USA Racquetball would be a perfect match for videogames and there couldn't be a better place to start than on the Wii(TM) system. This is literally a hands-on way of getting to know the USA Racquetball brand and the "Fast - Furious - Fitness" sport of racquetball. We look forward to playing the game ourselves."

    (Artwork and logo are available upon request.) About USA RACQUETBALL (USAR) ----------------------------

    USA Racquetball (USAR) is the National Governing Body for the sport of racquetball, recognized by the U.S. Olympic Committee and is committed to excellence and service to our members. USA Racquetball (USAR) as a governing body oversees the rules and events associated with Racquetball and supervises 50 state affiliates who govern 450-500 sanctioned Racquetball events annually. We provide opportunities for members and enthusiasts to actively participate in the sport through sanctioning of events, administration of programs and development of competitive teams. We provide racquetball opportunities in the sport of racquetball for all levels of participation through membership support, membership recruitment, promotion of the sport, maintaining competitive success and developing a network of sponsorships and supporters. For more information, please visit http://www.usaracquetball.com/.

    ABOUT SIGNATURE DEVICES, INC. AND GRAFFITI ENTERTAINMENT, INC: --------------------------------------------------------------

    Based in Redwood City, Calif., Signature Devices, Inc. creates, develops and manufactures advanced information technology, including computer systems, software and electronics products. One of the Company's premier technologies includes a blend of hardware and software for image generation technology used in video games and simulations. Signature Devices also owns Graffiti Entertainment, Inc. (http://www.graffitientertainment.com/), a publisher of interactive entertainment software for advanced entertainment consoles.

    The information in this press release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

    CONTACT: For More Information On USA Racquetball Contact Jim Hiser, USA Racquetball, (719) 635-5396x130, jhiser@usra.org; For More Information On Graffiti Entertainment Contact Investor Relations, (650) 654-4800x111, ir@signaturedevices.com, http://www.signaturedevices.com/; For More Information On USA Racquetball Licensing Contact Bonnie Kalter, Vice President, Marathon Projects, Ltd., (201) 796-3312, mplbonnie@aol.com

    Signature Devices, Inc.

    CONTACT: For More Information On USA Racquetball Contact Jim Hiser, USA
    Racquetball, (719) 635-5396x130, jhiser@usra.org; For More Information On
    Graffiti Entertainment Contact Investor Relations, (650) 654-4800x111,
    ir@signaturedevices.com, http://www.signaturedevices.com/; For More Information On USA
    Racquetball Licensing Contact Bonnie Kalter, Vice President, Marathon
    Projects, Ltd., (201) 796-3312, mplbonnie@aol.com




    MedQuist Announces Reseller Agreement With ClarioTechnology integration improves radiologist's efficiency by providing superior access to multiple information sources

    MT. LAUREL, N.J., Oct. 13 /PRNewswire-FirstCall/ -- MedQuist Inc. , a leading provider of clinical documentation workflow technology and services, and Clario Medical Imaging Inc. announced today they have agreed to expand their existing commercial relationship, to enable MedQuist to market and resell Clario's zVision(TM) software. The current partnership has already produced the integration of zVision with MedQuist's SpeechQ for Radiology(TM) real-time speech recognition solution.

    zVision aggregates information from SpeechQ, existing radiology information systems (RIS) and PACS, and other sources, then builds a database precisely customized for the radiology practice. The combined information is then presented at the radiologist's desktop in a single-view worklist format, to facilitate rapid workflow management and access to dictation using SpeechQ for Radiology.

    Clario's tool is particularly powerful in radiology environments in which RIS and PACS from multiple vendors are in use, since zVision permits convenient cross-platform data interfaces. It also offers critical results reporting, ability to select cases for peer review, and data retrieval to radiologists through a unique dashboard view.

    "We are delighted to collaborate with Clario -- an innovative organization with a unique understanding of the needs that radiology teams require," stated Peter Masanotti, President and CEO of MedQuist. "zVision's intelligent, feature-rich design enhances SpeechQ for Radiology to deliver all of the valuable information radiologists need in one place at one time."

    MedQuist will be demonstrating this integration in its booth (#8713) at RSNA 2009 (November 29 through December 4 in Chicago).

    About MedQuist

    MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com/.

    About Clario

    Clario partners with hospitals, imaging centers and private practice radiology groups to improve radiologists' efficiency through integration. Clario's flagship product, zVision, provides a benchmark unified worklist, intelligent real-time monitoring of practice statistics, advanced search, communication tracking and integrated peer review. For more information, visit http://www.clariomedical.com/

    "Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    MedQuist Inc.

    CONTACT: Robin Petty, Marketing Communications, +1-856-206-4715,
    rpetty@medquist.com

    Web Site: http://www.medquist.com/




    New York State Agencies Collecting Used Cell Phones to Benefit Domestic Violence SurvivorsStatewide Collection Taking Place in Recognition of National Domestic Violence Awareness Month - More than 150 state agency offices collecting old cell phones throughout October - Through Verizon Wireless' HopeLine(R) Program, phones will be refurbished, recycled or sold to benefit domestic violence survivors - Newer phones and program funding to be made available to domestic violence organizations statewide

    ALBANY, N.Y., Oct. 13 /PRNewswire/ -- In recognition of Domestic Violence Awareness Month, more than 150 state agency offices across New York State are collecting no-longer-used cellphones throughout October. Through Verizon Wireless' HopeLine Program, those phones will be recycled or refurbished and sold. Proceeds will be used to purchase wireless phones for domestic violence survivors and to make financial grants to domestic violence organizations in New York State.

    "By doing something as simple as donating an old wireless phone at one of these state agency offices, individuals can truly make a difference for a domestic violence survivor," said Marquett Smith, president of Verizon Wireless' Upstate New York Region. "We're proud to have the opportunity to work with Verizon Communications and the New York State Office for the Prevention of Domestic Violence (OPDV) to facilitate this collection and help domestic violence organizations across the state put an end to domestic violence in their communities."

    "New York State agencies are conducting these drives as part of our statewide 'Shine the Light on Domestic Violence' public awareness campaign," said Amy Barasch, Executive Director of the New York State Office for the Prevention of Domestic Violence. "Particularly in this time of fiscal crisis, Governor David A. Paterson is committed to maintaining support for domestic violence victims and we are pleased that we can strengthen grant-making opportunities for our nonprofit colleagues. We thank Verizon Wireless for their commitment to giving victims and the providers that serve them essential resources."

    Victims of domestic violence, family and friends can get help by calling the NYS Domestic & Sexual Violence Hotline:

    English and other languages: 1-800-942-6906 Spanish language: 1-800-942-6908 About Verizon Wireless

    Verizon Wireless operates the nation's most reliable and largest wireless voice and data network, serving 87.7 million customers. Headquartered in Basking Ridge, N.J., with more than 87,000 employees nationwide, Verizon Wireless is a joint venture of Verizon Communications and Vodafone (NYSE and LSE: VOD). For more information, visit http://www.verizonwireless.com/. To preview and request broadcast-quality video footage and high-resolution stills of Verizon Wireless operations, log on to the Verizon Wireless Multimedia Library at http://www.verizonwireless.com/multimedia.

    About HopeLine

    Verizon Wireless, a recognized corporate leader in the fight against domestic violence, works to combat domestic violence and raise awareness of the issue through the company's HopeLine program. Marking its 14th year in 2009, HopeLine today collects wireless phones and accessories from any wireless service provider, and then refurbishes the phones or recycles them in an environmentally friendly way. Proceeds from the HopeLine program benefit victims of domestic violence and non-profit advocacy agencies, providing essential communication tools of wireless phones and wireless services, and financial grants. Phone donations are accepted at all Verizon Wireless Stores across the country. For additional information, please visit http://www.verizonwireless.com/hopeline.

    About OPDV

    The New York State Office for the Prevention of Domestic Violence (OPDV) is a state agency charged with improving the response of state and local communities to domestic violence. OPDV provides guidance to Executive level staff on policy and legislation; conducts statewide community outreach and public education programs; and trains professionals on addressing domestic violence in a wide array of disciplines, including child welfare, law enforcement, local district social service providers, and health care professionals.

    Verizon Wireless

    CONTACT: John O'Malley, +1-585-321-7264 or +1-585-261-5899,
    john.omalley@verizonwireless.com, http://twitter.com/johnnyverizon; or Suzanne
    Cecala, +1-518-457-5744, Suzanne.cecala@opdv.state.ny.us,
    http://www.opdv.state.ny.us/

    Web Site: http://www.verizonwireless.com/

    Company News On-Call: http://www.prnewswire.com/comp/094251.html




    Video: H&R Block Helps Prepare Teens to be Financially Fit in the Real World

    KANSAS CITY, Mo., Oct. 13 /PRNewswire/ -- Although parents say they understand the importance of talking to their kids about money, teenagers are not learning what they need to be financially fit for the real world. A recent survey reveals that nearly 80 percent of parents feel it is very important to discuss personal finance with their teenagers, but when tested on their own knowledge of personal financial management, only 23 percent of the parents passed.(1) Research also shows that 50 percent of high school seniors received a grade of "F" when their general financial knowledge was put to the test.(2)

    To view the Multimedia News Release, go to: http://multivu.prnewswire.com/mnr/hrblock/39268/

    (Photo: http://www.newscom.com/cgi-bin/prnh/20091013/NY91786 )

    To increase teens' financial fitness and help them prepare for life after high school, H&R Block is donating more than $1 million in personal finance curriculum grants to high schools nationwide. Offered through its H&R Block Dollars & Sense(TM) program, the grants provide interactive software and lesson plans that assist teachers with personal finance instruction. The curriculum allows teens to experience real-life situations without real-life consequences. In addition to curriculum grants, H&R Block Dollars & Sense will offer college scholarships and online advice from a financial psychologist, Dr. Brad Klontz.

    Dr. Klontz is co-founder of Your Mental Wealth(TM) and CEO of Klontz Consulting Group. He works with H&R Block Dollars & Sense as a financial psychologist providing insight on personal finance management and advice on talking to teens about money.

    To date, only 21 states require some sort of personal finance education for high school students. The remaining states have no requirements, leaving individual schools the choice to implement personal finance instruction. However, it is financially difficult for many schools to add new subject matter into their curriculum offerings.

    "We educate teens regarding the dangers of drinking, drugs and other unhealthy behaviors, but financial stress can be just as damaging to our health," said Dr. Klontz. "Education on personal finance is often a neglected topic in schools, and H&R Block Dollars & Sense is setting out to help change that. It is imperative that parents and teachers talk to students and help them learn the basics of healthy financial behaviors. This will set the stage for improved financial fitness in the future--for our teens, our families, and our country."

    H&R Block has partnered with two leaders in the field of education to bring the program to life: Knowledge Matters, a provider of simulation-based educational software, and DECA, an international student organization that works to improve education and career opportunities for students. The Virtual Business®-Personal Finance software from Knowledge Matters offers students realistic situations and challenges around 18 financial topics, such as managing a budget, handling taxes, avoiding credit card debt, saving and investing.

    To learn more about H&R Block Dollars & Sense, visit http://www.hrblockdollarsandsense.com/.

    About the Partners

    H&R Block Inc. is the world's preeminent tax services provider, providing income tax return preparation and related services and products via a nationwide network of approximately 13,000 company-owned and franchised offices.

    H&R Block launched H&R Block Dollars & Sense(TM) to increase the financial fitness of high school students through a partnership with Knowledge Matters and DECA. Knowledge Matters is a leading developer and publisher of educational software. Its products have been used by more than 500,000 students across the world. DECA is an international student organization with over 185,000 student members. DECA is committed to the advocacy of marketing education and the growth of business and education partnerships.

    1. The University of Kansas 2. Jumpstart Coalition Media contacts Viva Bolova 816-423-6051 vbolova@barkleyus.com Kevin Gabriel 816-423-6103 kgabriel@barkleyus.com

    Photo: http://www.newscom.com/cgi-bin/prnh/20091013/NY91786
    PRN Photo Desk, photodesk@prnewswire.com Video: http://multivu.prnewswire.com/mnr/hrblock/39268 H&R Block

    CONTACT: Viva Bolova, +1-816-423-6051, vbolova@barkleyus.com; or Kevin
    Gabriel, +1-816-423-6103, kgabriel@barkleyus.com

    Web Site: http://www.hrblockdollarsandsense.com/




    Bebida Beverages In Alliance With Potencia USA Introduce New Distribution Partner

    MOORESVILLE, NC, Oct. 13 /PRNewswire-FirstCall/ -- (bbda.pk) Bebida Beverages Company in association with Potencia USA LLC are proud to announce their newest partner in the distribution of their beverage lines. Southeast Beverage Distributing of China Grove, NC is excited about the potential it sees in the new Koma Unwind "Chillaxation Drink". Southeast Beverage Distributing services nearly 300 stores in and around Charlotte, NC offering soft drinks and other beverages.

    They are very excited about introducing Koma Unwind and establishing a relationship with Bebida Beverages. Southeast Beverage Distributing also is anxiously awaiting new products from Bebida Beverages, including the 2 oz. Koma Unwind "Chillaxation Shot".

    "We are glad to have Southeast Beverage Distributing involved in our exciting new line of beverages", stated CEO Brian Weber, "They are an established distributor in the area, and they were excited about the potential of our new product."

    POTENCIA Energy Drink is a 3 year old all natural fruit energy drink developed for Latinos but loved by everyone! With the initial flavor of Tamarind and the second flavor mandarin due out soon.

    Bebida Beverages Co. is the maker and developer of several beverages including: Piranha Water, Guppy Water, Koma Unwind (Relaxation Beverage) and Koma Shot.

    Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

    CONTACT: IR Contact: Chris Hoffmann, C. Hoffmann Communications, Inc., (714) 594-7357, choffmannjr@gmail.com; http://www.bebidabeverages.com/; http://www.piranhabeverages.com/; http://www.potenciaenergydrink.com/; http://www.awginc.com/

    Bebida Beverage Company

    CONTACT: IR Contact: Chris Hoffmann, C. Hoffmann Communications, Inc.,
    (714) 594-7357, choffmannjr@gmail.com; http://www.bebidabeverages.com/;
    http://www.piranhabeverages.com/; http://www.potenciaenergydrink.com/; http://www.awginc.com/




    Grandunion Inc. Acquires Control of Aries Maritime Transport Limited

    ATHENS, Greece, Oct. 13 /PRNewswire/ -- Aries Maritime Transport Limited ("Aries") announced today that Grandunion Inc. ("Grandunion"), a company controlled by Michail S. Zolotas and Nicholas G. Fistes, acquired 18,977,778 newly issued common shares in Aries in exchange for three capesize drybulk carriers. Of such shares, 2,666,667 were transferred to Rocket Marine Inc., a company controlled by two former directors and principal shareholders in Aries, in exchange for Rocket and its affiliates entering into a voting agreement with Grandunion. Under this voting agreement, Grandunion controls the voting rights relating to the shares owned by Rocket and its affiliates. Grandunion now owns approximately 34.2% of Aries and, as a result of the voting agreement controls the vote of approximately 71% of Aries' outstanding shares.

    "The closing marks a new era for Aries. We have already expended significant effort in restructuring the loan with the existing lending syndicate and bringing in new, much needed financing. As a result, we will have a stable balance sheet with which we can operate," said Nicholas G. Fistes, Chairman of Aries. Mr. Fistes continued, "Our interests are aligned with the existing shareholders, as we have invested in Aries and acquired a significant equity position with the belief that we can create value in the long run. We can immediately benefit through Grandunion's technical and operational expertise and industry relationships."

    Mr. Zolotas, Deputy Chairman and Chief Executive Officer of Aries, added, "We will immediately focus on repositioning Aries, with a view to opportunistically expanding in the drybulk and tanker sectors. We will also leverage our operating expertise by bringing in-house technical and commercial management, reducing operating expenses, increasing vessel utilization and otherwise streamlining operations."

    Mr. Allan Shaw, Chief Financial Officer, stated, "We intend to adopt transparent corporate governance practices and financial reporting as we emphasize an internal culture of corporate responsibility and accountability in creating shareholder value."

    Management and Board Constituency

    The new management of the Company will be led by Nicholas G. Fistes as Executive Chairman, Michail S. Zolotas as Chief Executive Officer and Allan Shaw as Chief Financial Officer. The new management team intends to build the technical and commercial group of Aries and incorporate the existing Aries team into their operations

    The full Board is set forth below: -- Mr. Nicholas G. Fistes - Executive Chairman; -- Mr. Michail S. Zolotas - Deputy Chairman -- Mr. Allan Shaw - Director -- Mr. Masaaki Kohsaka - Non-Executive Director -- Mr. Spyros Gianniotis - Non-executive Director -- Mr. Apostolos Tsitsirakis - Non-executive Director; and -- Mr. Panagiotis Skiadas - Non-executive Director Financing Arrangements Convertible Notes

    The Company has issued $145 million in aggregate principal amount of 7% senior unsecured convertible notes due 2015 (the "Convertible Notes"), convertible into common shares at a conversion price of $0.75 per share. Investment Bank of Greece currently holds a small portion of the outstanding principal amount and the remainder is owned by a company controlled by Mr. Zolotas, financed by Marfin Egnatia Bank S.A. The proceeds of the Convertible Notes are expected to be used for general corporate purposes, to fund vessel acquisitions and to partially repay existing indebtedness.

    Bank Financing

    Aries' existing syndicate of lenders has entered into a new $221,429,999 Facility Agreement to refinance Aries' existing revolving credit facility. The Company has applied $20 million of the bond proceeds to pay down the new credit facility, which has been structured to provide favorable amortization, with $163.4 million repayment due at the end of the five year term.

    Fleet Composition Post closing, Aries' 14 vessel fleet will consists of: -- four Panamax tankers (all double-hulled) -- five MR tankers (three double-hulled) -- two container vessels (2,917 TEU) -- three capesize drybulk vessels totaling 477,000 dwt

    Five of the Company's 14 vessels are secured on period charters. Charters for two of the Company's products tanker vessels currently have profit-sharing components as well as one capesize vessel.

    Advisors

    S. Goldman Advisors LLC acted as financial advisor to Grandunion Inc., with Mintz Levin acting as lead counsel and V&P Law Firm acting as admiralty and local counsel.

    About Aries Maritime Transport Limited

    Aries Maritime Transport Limited is an international shipping company that owns and operates products tankers, container vessels and drybulk carriers. For more information please visit our website at http://www.ariesmaritime.com/.

    Forward-Looking Statements

    This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include matters that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from results expressed or implied by this press release. Actual results may differ Aries undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after the date of this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement.

    CONTACT: Investor Relations CJP Communications Laura Kowalcyk +1 212 279 3115 (x209) lkowalcyk@cjpcom.com

    Grandunion Inc.

    CONTACT: Laura Kowalcyk of CJP Communications, +1-212-279-3115 ext. 209,
    lkowalcyk@cjpcom.com




    First South Bancorp, Inc. Reports September 30, 2009 Quarterly and Nine Months Earnings

    WASHINGTON, N.C., Oct. 13 /PRNewswire-FirstCall/ -- First South Bancorp, Inc. (the "Company"), the parent holding company of First South Bank (the "Bank"), reports its earnings for the quarter ended September 30, 2009 (unaudited) and its earnings for the nine months ended September 30, 2009 (unaudited).

    Net income was $1.8 million ($0.18 per share diluted) for both the 2009 third quarter and the linked 2009 second quarter, compared to $2.1 million ($0.21 per share diluted) for the 2008 third quarter. Net income for the first nine months of 2009 was $5.5 million ($0.57 per share diluted), compared to net income of $9.0 million ($0.93 per share diluted) for the first nine months of 2008.

    The Bank recorded provisions for credit losses of $1.3 million in the 2009 third quarter and $1.7 million in both the linked 2009 second quarter and the comparative 2008 third quarter. Credit loss provisions were necessary to replenish net charge-offs and strengthen the allowance for credit losses at levels the Bank believes is adequate to absorb probable losses in the loan portfolio. The allowance for credit losses was $12.6 million at September 30, 2009, representing 1.8% of total loans and leases.

    "The increase in our allowance for credit losses over the past several quarters is the result of our internal risk grading analysis and is primarily attributable to our commercial real estate portfolio," said Bill Wall, executive vice president and chief financial officer. "We have taken a conservative posture in our provisioning for credit losses as we continue to aggressively manage problem assets. We believe the current level of our allowance for credit losses is adequate, however, there is no assurance in the future that regulators, increased risks in the loan portfolio, or changes in economic conditions will not require additional adjustments to the allowance for credit losses," said Wall.

    "The Company remains profitable, continues to maintain a strong capital position in excess of the well-capitalized regulatory guidelines, and combined with strengthening of the allowance for credit losses should enhance our future earnings when economic conditions improve," stated Wall.

    Net interest income increased to $8.3 million for the 2009 third quarter from $7.9 for the linked 2009 second quarter, compared to $9.0 million for the 2008 third quarter. The increase in net interest income in the current quarter has been influenced by deposit repricing and the rollover of maturing time deposits at lower interest rates. The net interest spread was 4.1% for the 2009 third quarter, 3.8% for the linked 2009 second quarter and 4.2% for the comparative 2008 third quarter.

    Total non-interest income was $2.4 million for the 2009 third quarter, $3.2 million for the linked 2009 second quarter and $2.4 million for the 2008 third quarter. The Bank maintained a consistent level of revenue across both loan and deposit service offerings as loan fees, deposit fees and service charges and servicing fee income was $2.0 million in the 2009 third quarter and $2.1 million in both the linked 2009 second quarter and the comparative 2008 third quarter.

    Net gains recognized from the sale mortgage loans, mortgage-backed securities and investment securities was $247,000 in the 2009 third quarter, $883,000 in the linked 2009 second quarter and $136,000 in the comparative 2008 third quarter.

    Total non-interest expense was $6.5 million for both the 2009 third quarter and the linked 2009 second quarter, compared to $6.3 million for 2008 third quarter. Compensation and fringe benefits, the largest component of non-interest expense, has remained relatively consistent at $3.5 million for the 2009 third quarter, $3.6 million for the linked 2009 second quarter, and $3.4 million for the comparative 2008 third quarter, reflecting the Bank's efforts of managing its human resources cost. FDIC insurance premiums were $275,000 for the 2009 third quarter, $540,000 for the linked 2009 second quarter (reflecting the FDIC's $400,000 mandatory 5 basis point special assessment), and $109,000 for the comparative 2008 third quarter.

    Total assets were $855.9 million at September 30, 2009, compared to $875.9 million at December 31, 2008. Total loans declined to $681.7 million at September 30, 2009 from $744.7 million at December 31, 2008. Mortgage-backed securities increased to $86.3 million at September 30, 2009 from $32.8 million at December 31, 2008, reflecting the securitization of certain mortgage loans during 2009. Cash, interest bearing deposits and investment securities was $46.7 million at September 30, 2009 and $63.3 million at December 31, 2008.

    Nonaccrual loans declined to $7.1 million at September 30, 2009 from $10.7 million at December 31, 2008, reflecting management's efforts of managing problem assets and improving credit quality. Management believes it has thoroughly evaluated its nonaccrual loans and they are either well collateralized or adequately reserved.

    Other real estate owned increased to $12.5 million at September 30, 2009 from $7.7 million at December 31, 2008, reflecting a rise in foreclosures of certain real estate properties during 2009. Based on fair value analysis, the Bank believes the adjusted carrying values of these real estate properties are representative of their fair market values, although there are no assurances that the ultimate sales prices will be equal to or greater than the carrying values.

    Total deposits declined to $709.9 million at September 30, 2009 from $716.4 million at December 31, 2008, while borrowings declined to $39.0 million at September 30, 2009 from $52.6 million at December 31, 2008. The cost of funds for the 2009 third quarter improved to 2.0%, from 2.3% for the linked 2009 second quarter and 2.7% for the comparative 2008 third quarter. The Bank has been able to improve its cost of funds by the combination of pricing new deposits, the renewal of maturing time deposits and the repositioning of borrowings within the current lower interest rate environment.

    First South Bank has been serving the citizens of eastern North Carolina since 1902 and offers a variety of financial products and services, including a leasing company. Securities brokerage services are made available through an affiliation with an independent broker/dealer. The Bank operates through its main office headquartered in Washington, North Carolina, and has 28 full service branch offices and two loan production offices located throughout central, eastern, northeastern and southeastern North Carolina.

    First South Bancorp, Inc. may be accessed on its website at http://www.firstsouthnc.com/. The Company's common stock symbol as traded on the NASDAQ Global Select Market is "FSBK".

    Statements contained in this release, which are not historical facts, are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors which include the effects of future economic conditions, governmental fiscal and monetary policies, legislative and regulatory changes, the risks of changes in interest rates, the effects of competition, and including without limitation to other factors that could cause actual results to differ materially as discussed in documents filed by the Company with the Securities and Exchange Commission from time to time.

    For more information contact: Bill Wall (CFO) or Tom Vann (CEO) Phone: (252) 946-4178 Website: http://www.firstsouthnc.com/ First South Bancorp, Inc. and Subsidiary Consolidated Statements of Financial Condition September 30 December 31 2009 2008* ---- ---- Assets (unaudited) Cash and due from banks $16,426,912 $20,888,676 Interest-bearing deposits in financial institutions 24,882,380 5,831,683 Investment securities - available for sale 5,431,669 36,563,646 Mortgage-backed securities - available for sale 85,677,465 31,995,157 Mortgage-backed securities - held for investment 597,170 832,221 Loans and leases receivable, net: Held for sale 7,395,152 5,566,262 Held for investment 674,301,261 739,165,035 Premises and equipment, net 8,608,313 9,049,929 Real estate owned 12,474,026 7,710,560 Federal Home Loan Bank of Atlanta stock, at cost which approximates market 3,889,500 3,658,600 Accrued interest receivable 3,425,955 3,786,760 Goodwill 4,218,575 4,218,576 Mortgage servicing rights 1,247,265 1,005,725 Identifiable intangible assets 141,480 165,060 Prepaid expenses and other assets 7,216,244 5,417,231 --------- --------- Total assets $855,933,367 $875,855,121 ============ ============ Liabilities and Stockholders' Equity Deposits: Demand $220,017,625 $223,365,542 Savings 23,407,287 26,555,881 Large denomination certificates of deposit 236,658,259 207,102,876 Other time 229,768,022 259,402,497 ----------- ----------- Total deposits 709,851,193 716,426,796 Borrowed money 39,040,146 52,558,492 Junior subordinated debentures 10,310,000 10,310,000 Other liabilities 9,451,493 8,738,808 --------- --------- Total liabilities 768,652,832 788,034,096 Common stock, $.01 par value, 25,000,000 shares authorized; 11,254,222 issued; 9,740,596 shares outstanding 97,406 97,381 Additional paid-in capital 35,842,550 35,924,426 Retained earnings, substantially restricted 82,549,803 82,867,095 Treasury stock at cost (32,194,216) (32,247,365) Accumulated other comprehensive income, net 984,992 1,179,488 ------- --------- Total stockholders' equity 87,280,535 87,821,025 ---------- ---------- Total liabilities and stockholders' equity $855,933,367 $875,855,121 ============ ============ *Derived from audited consolidated financial statements First South Bancorp, Inc. and Subsidiary Consolidated Statements of Operations (unaudited) Three Months Ended Nine Months Ended September 30 September 30 ------------ ------------ 2009 2008 2009 2008 ---- ---- ---- ---- Interest income: Interest and fees on loans $11,162,577 $13,379,203 $34,428,527 $42,721,576 Interest and dividends on investments and deposits 1,033,088 1,010,107 2,779,797 3,269,998 --------- --------- --------- --------- Total interest income 12,195,665 14,389,310 37,208,324 45,991,574 ---------- ---------- ---------- ---------- Interest expense: Interest on deposits 3,537,810 4,864,737 11,815,289 16,556,440 Interest on borrowings 293,355 399,500 974,106 1,194,757 Interest on junior subordinated notes 90,658 146,960 307,966 487,915 ------ ------- ------- ------- Total interest expense 3,921,823 5,411,197 13,097,361 18,239,112 --------- --------- ---------- ---------- Net interest income 8,273,842 8,978,113 24,110,963 27,752,462 Provision for credit losses 1,260,000 1,744,916 4,480,000 2,893,600 --------- --------- --------- --------- Net interest income after provision for credit losses 7,013,842 7,233,197 19,630,963 24,858,862 --------- --------- ---------- ---------- Non-interest income: Fees and service charges 1,835,435 1,897,939 5,477,372 5,879,783 Loan servicing fees 173,967 163,967 496,795 490,496 Gain (loss) on sale of real estate, net (86,875) (3,664) (161,323) 96,837 Gain on sale of mortgage loans 247,189 108,316 935,291 512,544 Gain on sale of mortgage-backed securities - 27,626 - 97,537 Gain on sale of investment securities - - 917,866 - Other income 231,313 246,401 768,081 857,348 ------- ------- ------- ------- Total non-interest income 2,401,029 2,440,585 8,434,082 7,934,545 --------- --------- --------- --------- Non-interest expense: Compensation and fringe benefits 3,524,025 3,401,733 10,523,200 10,440,902 Federal insurance premiums 274,908 109,413 955,117 153,190 Premises and equipment 451,967 500,037 1,371,822 1,512,625 Advertising 37,155 23,637 100,171 86,941 Payroll and other taxes 330,426 276,201 1,017,520 970,764 Data processing 625,837 686,707 1,829,505 1,953,777 Amortization of intangible assets 122,003 103,108 371,334 331,910 Other 1,164,154 1,221,041 2,877,064 2,727,470 --------- --------- --------- --------- Total non-interest expense 6,530,475 6,321,877 19,045,733 18,177,579 --------- --------- ---------- ---------- Income before income taxes 2,884,396 3,351,905 9,019,312 14,615,828 Income taxes 1,122,727 1,296,251 3,493,246 5,647,470 --------- --------- --------- --------- Net income $1,761,669 $2,055,654 $5,526,066 $8,968,358 ========== ========== ========== ========== Per share data: Basic earnings per share $0.18 $0.21 $0.57 $0.93 Diluted earnings per share $0.18 $0.21 $0.57 $0.93 Dividends per share $0.20 $0.20 $0.60 $0.60 Weighted average shares-Basic 9,738,475 9,751,221 9,738,225 9,719,512 Weighted average shares-Diluted 9,738,550 9,768,515 9,738,250 9,743,727 First South Bancorp, Inc. Supplemental Quarterly Financial Data (Unaudited) 9/30/2009 6/30/2009 3/31/2009 12/31/2008 9/30/2008 --------- --------- --------- ---------- --------- Consolidated balance (dollars in thousands except per share data) sheet data: Total assets $855,933 $886,192 $875,850 $875,855 $888,633 Loans receivable (net): Mortgage 49,944 53,537 60,132 46,252 44,035 Commercial 528,216 547,904 566,706 585,893 590,212 Consumer 92,809 94,749 98,292 101,180 102,929 Leases 10,727 9,717 10,692 11,406 12,546 ------ ----- ------ ------ ------ Total 681,696 705,907 735,822 744,731 749,722 Cash and investments 46,741 57,342 50,867 63,284 69,176 Mortgage-backed securities 86,275 81,596 51,100 32,827 32,503 Premises and equipment 8,608 8,714 8,866 9,050 9,234 Goodwill 4,219 4,219 4,219 4,219 4,219 Mortgage servicing rights 1,247 1,230 1,079 1,006 1,076 Deposits: Savings 23,407 24,730 26,561 26,556 18,249 Checking 220,018 225,647 224,249 223,366 229,271 Certificates 466,426 480,634 469,624 466,505 475,350 ------- ------- ------- ------- ------- Total 709,851 731,011 720,434 716,427 722,870 Borrowings 39,040 49,695 49,606 52,558 57,772 Junior subordinated debentures 10,310 10,310 10,310 10,310 10,310 Stockholders' equity 87,281 86,708 87,785 87,821 86,824 Consolidated earnings summary: Interest income $12,196 $12,442 $12,571 $13,372 $14,389 Interest expense 3,922 4,546 4,629 5,078 5,411 ----- ----- ----- ----- ----- Net interest income 8,274 7,896 7,942 8,294 8,978 Provision for credit losses 1,260 1,700 1,520 1,150 1,745 Noninterest income 2,401 3,212 2,821 2,149 2,441 Noninterest expense 6,530 6,513 6,002 5,987 6,322 Income taxes 1,123 1,135 1,236 1,287 1,296 ----- ----- ----- ----- ----- Net income $1,762 $1,760 $2,005 $2,019 $2,056 ====== ====== ====== ====== ====== Per Share Data: Earnings per share- Basic $0.18 $0.18 $0.21 $0.21 $0.21 Earnings per share- Diluted $0.18 $0.18 $0.21 $0.21 $0.21 Dividends per share $0.20 $0.20 $0.20 $0.20 $0.20 Book value per share $8.96 $8.90 $9.01 $9.02 $8.92 Average shares- Basic 9,738,475 9,738,096 9,738,096 9,738,096 9,751,221 Average shares- Diluted 9,738,550 9,738,096 9,738,096 9,743,987 9,768,515 9/30/2009 6/30/2009 12/31/2008 12/31/2008 9/30/2008 --------- --------- ---------- ---------- --------- (dollars in thousands except per share data) Performance ratios: Yield on earning assets 6.09% 6.10% 6.19% 6.57% 6.93% Cost of funds 2.03% 2.32% 2.37% 2.59% 2.71% ---- ---- ---- ---- ---- Net interest spread 4.06% 3.78% 3.82% 3.98% 4.22% Net interest margin on earning assets 4.13% 3.87% 3.91% 4.08% 4.32% Earning assets to total assets 92.38% 92.43% 92.79% 92.29% 92.03% Return on average assets 0.81% 0.80% 0.91% 0.92% 0.92% Return on average equity 8.06% 7.98% 9.07% 9.19% 9.37% Efficiency ratio 61.10% 58.57% 55.70% 57.25% 55.30% Dividend payout ratio 111.11% 111.11% 95.24% 95.24% 95.24% Average assets $867,976 $881,307 $878,795 $879,864 $898,349 Average earning assets $801,625 $816,210 $812,831 $813,993 $830,759 Average equity $87,418 $88,240 $88,443 $87,876 $87,737 Equity/Assets 10.20% 9.78% 10.02% 10.02% 9.77% Tangible Equity/ Assets 9.69% 9.29% 9.52% 9.53% 9.28% Asset quality data and ratios: Nonaccrual loans $7,132 $7,609 $6,940 $10,727 $8,510 Restructured loans $4,304 $4,304 $4,276 $4,275 $4,017 ------ ------ ------ ------ ------ Total nonperforming loans $11,436 $11,913 $11,216 $15,002 $12,527 Other real estate owned $12,474 $10,408 $10,573 $7,711 $6,987 ------- ------- ------- ------ ------ Total nonperforming assets $23,910 $22,321 $21,789 $22,713 $19,514 Allowance for loan and lease losses $12,318 $11,726 $10,878 $11,618 $11,284 Allowance for unfunded loan commitments $269 $269 $312 $340 $378 ---- ---- ---- ---- ---- Allowance for credit losses $12,587 $11,995 $11,190 $11,958 $11,662 Allowance for loan and lease losses to loans 1.77% 1.63% 1.45% 1.53% 1.48% Allowance for unfunded loan commitments to unfunded commitments 0.29% 0.28% 0.30% 0.29% 0.28% ---- ---- ---- ---- ---- Allowance for credit losses to loans 1.81% 1.67% 1.50% 1.58% 1.53% Net charge-offs (recoveries) $668 $894 $2,288 $854 $431 Net charge-offs (recoveries) to loans 0.098% 0.127% 0.311% 0.115% 0.057% Nonperforming loans to loans 1.68% 1.69% 1.52% 2.01% 1.67% Nonperforming assets to assets 2.79% 2.52% 2.49% 2.59% 2.20% Loans to deposits 96.03% 96.57% 102.16% 103.95% 103.71% Loans to assets 79.64% 79.66% 84.03% 85.03% 84.37% Loans serviced for others $281,935 $268,266 $254,195 $255,510 $259,326

    First South Bancorp, Inc.

    CONTACT: Bill Wall (CFO) or Tom Vann (CEO) of First South Bancorp,
    +1-252-946-4178

    Web Site: http://www.firstsouthnc.com/




    Raptor Pharmaceutical annonce des résultats intermédiaires positifs de ses essais cliniques de phase 2a sur la stéatohépatite non alcoolique (NASH)

    NOVATO, Californie, October 13 /PRNewswire/ --

    - Critère d'évaluation primaire satisfait au moment de la finalisation de la phase de traitement

    Raptor Pharmaceutical Corp. (<< Raptor >> ou la << Société >>) (Nasdaq : RPTPD), a annoncé des conclusions positives à la suite de la finalisation de la phase de traitement de son essai clinique de phase 2a ouvert sur le bitartrate de cystéamine à action retardée (<< DR Cysteamine >>) sur des patients adolescents atteints de stéatohépatite non alcoolique (<< NASH >>), une forme progressive d'hépatopathie qui affecterait entre 2 et 5 % de la population des États-Unis. Au moment de la finalisation de la phase initiale du traitement de six mois, l'étude a satisfait le critère d'évaluation primaire : les niveaux moyens dans le sang d'alanine aminotransférase (<< ALT >>), un biomarqueur habituel de la NASH, ont diminué de plus de 50 %. En outre, plus de la moitié des participants à l'étude présentaient des niveaux d'ALT normaux à la fin de la phase de traitement.

    (Logo : http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO)

    Il n'existe actuellement aucun traitement médicamenteux autorisé pour la NASH et la seule façon pour les patients de gérer la maladie c'est de changer de style de vie en suivant, par exemple, un régime, en faisant de l'exercice physique et en perdant du poids. DR Cysteamine constitue une option de traitement potentielle importante pour les patients atteints de NASH. S'il est vrai que la NASH affecte le plus souvent des adultes obèses présentant un profil de diabète insulinorésistant et des lipides sériques anormaux, de plus en plus de jeunes sont néanmoins touchés en raison de l'augmentation du taux d'obésité au sein de cette population de patients. Malgré le fait que la plupart des patients sont asymptomatiques et se sentent en bonne santé, la NASH provoque un ralentissement du fonctionnement du foie et peut entraîner une cirrhose, une insuffisance hépatique et une maladie hépatique en étape terminale.

    L'essai ouvert de phase 2a du prototype de formulation de DR Cysteamine est mené dans le cadre d'un accord de collaboration entre Raptor et l'Université de Californie à San Diego (<< UC San Diego >>), au Centre de recherche clinique générale de l'UC San Diego, et implique six mois de traitement suivis d'une période de six mois de suivi post-traitement. Les patients éligibles, présentant des niveaux de base d'ALT et d'aspartate aminotransférase (<< AST >>) au moins deux fois supérieurs aux niveaux normaux, ont été recrutés pour recevoir des doses orales biquotidiennes croissantes allant jusqu'à 1 000 mg de DR Cysteamine. L'essai concerne actuellement onze patientes atteints d'une NASH et âgés d'entre 11 et 18 ans. Aucun événement important néfaste n'a été signalé au cours de la phase de traitement de six mois. Les sujets de l'essai continueront d'être suivis pendant six mois, la période post-traitement actuellement en cours. Les résultats complets sont en passe d'être soumis par Raptor et UC San Diego en vue de leur révision par les pairs, et devraient être présentés en 2010.

    Joel Lavine, docteur en médecine, Ph. D., pédiatre gastroentérologue à l'UC San Diego et chercheur principal dans le cadre de l'étude sur la NASH, a déclaré : << Nous sommes encouragés par les résultats de cette étude. Le degré de diminution des ALT et AST indique de probables atténuations de la gravité de l'hépatite graisseuse. Les résultats de l'étude sont en accord avec les diminutions d'ALT et AST normalement observées chez les patients ayant réussi à perdre au moins 10 % de leur poids, alors que les indices de masse corporelle les participants à l'étude n'ont pas évolué de manière importante. DR Cysteamine semble être un candidat prometteur pour la NASH et nous sommes impatients de continuer d'analyser ces patients pendant la phase post-traitement >>.

    Patrice Rioux, docteur en médecine, Ph. D. et médecin en chef chez Raptor, a affirmé : << Ces résultats intermédiaires ont apporté une démonstration de faisabilité et soutiennent la continuation de la mise au point clinique de DR Cysteamine pour la NASH. Ceci est un domaine présentant d'importants besoins insatisfaits, surtout avec le nombre croissant d'enfants obèses à qui l'on diagnostique cette maladie. Malgré le fait que le défi clinique est souvent difficile à surmonter pour les études sur les enfants et les adolescents, nous sommes néanmoins satisfaits par la sécurité sur le long terme qui a été prouvée dans cette catégorie d'âge par la formulation actuellement commercialisée de bitartrate de cystéamine à action immédiate. Ces antécédents de sécurité, associés avec nos résultats intermédiaires d'efficacité en phase 2a, nous encouragent vivement à mesure que nous faisons avancer DR Cysteamine à travers l'étude clinique >>.

    Sous licence avec l'UC San Diego, Raptor est en passe de mettre au point DR Cysteamine pour la cystinose, la NASH d'autres indications thérapeutiques potentielles. La cystéamine est connue pour son rôle de désactivateur d'espèces oxygènes et comme antioxydant puissant, très probablement en raison de sa capacité à augmenter les niveaux de glutathion intercellulaire. La cystéamine a également fait preuve d'une efficacité potentielle dans les études précliniques et cliniques sur la maladie de Huntington, la maladie de Batten et d'autres indications.

    À propos de Raptor Pharmaceutical Corp.

    Raptor Pharmaceutical Corp. (Nasdaq : RPTPD) (<< Raptor >>) se consacre à l'accélération du développement de nouvelles options de traitement pour le bénéfice des patients à travers l'amélioration des médicaments existants et grâce à l'application de plates-formes de ciblage de médicament très spécialisées et à une expertise en formulation. La Société se concentre sur les populations de patients mal prises en charge sur lesquelles les travaux de la Société peuvent avoir le plus grand impact. À l'heure actuelle, Raptor possède des produits candidats en développement clinique pour le traitement de la cystinose néphropathique, la stéatohépatite non alcoolique (<< NASH >>), la maladie de Huntington (<< HD >>), le déficit en aldéhyde déshydrogénase (<< ALDH2 >>) et une solution non-opioïde conçue contre la douleur chronique et la thrombose.

    Les programmes précliniques de Raptor sont basés sur la bioingénierie de nouveaux médicaments candidats et de nouvelles plates-formes de ciblage de médicaments tirés de la protéine humaine associée au récepteur (<< RAP >>) et des protéines associées conçues pour le traitement du cancer, des troubles neurodégénératifs et des maladies infectieuses.

    Pour plus de renseignements, veuillez consulter www.raptorpharma.com.

    ÉNONCÉS PROSPECTIFS

    Le présent document contient des énoncés prospectifs au sens de la loi Private Securities Litigation Reform Act de 1995. Ces énoncés se réfèrent à des événements, des résultats d'exploitation ou le rendement financier futurs, y compris, mais sans s'y limiter, aux énoncés selon lesquels : la capacité de Raptor et d'UC San Diego à finaliser l'essai clinique sur les patients atteints de NASH, la capacité du DR Cysteamine à traiter la NASH, en utilisant les ALT et AST comme biomarqueurs pour déterminer l'efficacité du traitement de la NASH, la capacité de Raptor à poursuivre le développement du DR Cysteamine pour la NASH et d'autres indications. Ces énoncés ne sont que des prévisions et impliquent des risques, des incertitudes et d'autres facteurs connus et inconnus susceptibles de causer des écarts considérables entre les résultats réels de la Société et ces énoncés prospectifs. Les facteurs pouvant considérablement modifier ou empêcher les énoncés prospectifs de la Société de se réaliser comprennent le fait que Raptor échoue dans la mise au point de tout produit ou l'acquisition de produits ; que la technologie de Raptor ne soit pas validée à mesure qu'elle continue de se développer et que ses méthodes ne soient pas acceptées par la communauté scientifique ; que Raptor soit incapable de retenir ou d'attirer des employés clés dont les connaissances sont essentielles à la mise au point de ses produits ; que des difficultés inattendues surgissent au cours du processus de la Société : que les brevets de Raptor ne suffisent pas à protéger les aspects essentiels de sa technologie ; que la concurrence invente une meilleure technologie ; que les produits de Raptor ne fonctionnent pas ou pire encore que les produits de la Société fassent du mal aux receveurs ; et que Raptor ne soit pas capable de collecter assez de fonds pour le développement ou pour les fonds de roulement. De plus, il est possible que les produits de Raptor ne deviennent jamais des produits utiles et même s'ils le deviennent, il est possible qu'ils ne soient pas autorisés pour la vente au public. Raptor avertit les lecteurs de ne pas trop se fier aux énoncés prospectifs qui ne sont valides qu'à la date du présent communiqué. Certains de ces risques, incertitudes et autres facteurs sont décrits de façon plus détaillée dans les documents déposés par Raptor de façon périodique auprès de la Securities and Exchange Commission (la << SEC >>), dont Raptor recommande fortement la lecture et la prise en considération, y compris le prospectus/la déclaration conjointe sur formulaire S-4 déposé auprès de la SEC le 19 août 2009 ; le rapport annuel de Raptor sur formulaire 10-K déposé auprès de la SEC le 27 mars 2009 ; le rapport trimestriel de Raptor sur formulaire 10-Q déposé auprès de la SEC le 11 août 2009 ; la déclaration d'enregistrement sur formulaire S-1 de la filiale à 100 % de Raptor, Raptor Pharmaceuticals Corp. (<< RPC >>), dans sa version modifiée, qui a été déclarée effective à compter du 7 août 2008 ; le rapport annuel de RPC sur formulaire 10-K, déposé auprès de la SEC le 30 octobre 2008, dans sa version modifiée sur formulaire 10-K/A déposé auprès de la SEC le 23 décembre 2008 ; et le rapport trimestriel de RPC sur formulaire 10-Q, déposé auprès de la SEC le 15 juillet 2009, tous ces documents étant disponibles gratuitement sur le site Web de la SEC http://www.sec.gov. Les énoncés prospectifs ultérieurs, écrits ou oraux, attribuables à Raptor ou à des personnes agissant au nom de celle-ci sont totalement couverts par les avertissements contenus dans les rapports de Raptor déposés auprès de la SEC. Nous nous dégageons expressément de toute intention ou obligation de remettre à jour tout énoncé prospectif.

    Pour plus d'informations, veuillez contacter : Karl Cahill, Relations avec les investisseurs +1-858-531-6100 kcahill@raptorpharma.com The Ruth Group Sara Ephraim Pellegrino (investisseurs) +1-646-536-7002 spellegrino@theruthgroup.com Janine McCargo (médias) +1-646-536-7033 jmccargo@theruthgroup.com

    Raptor Pharmaceutical Corp.

    Karl Cahill, Relations avec les investisseurs, +1-858-531-6100, kcahill@raptorpharma.com ; ou Sara Ephraim Pellegrino (investisseurs), +1-646-536-7002, spellegrino@theruthgroup.com ou Janine McCargo (médias), +1-646-536-7033, jmccargo@theruthgroup.com, toutes deux chez The Ruth Group




    Savvis Announces Time for Third Quarter 2009 Earnings Call

    ST. LOUIS, October 13 /PRNewswire/ --

    Savvis, Inc. (Nasdaq: SVVS), a global leader in IT infrastructure services, today announced that it plans to release its third quarter 2009 financial results before the market opens on Wednesday, October 28, 2009. Company executives will host a financial analyst call at 10:00 a.m. ET that morning, to discuss third quarter earnings and to provide a general business update.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20090803/PH55929LOGO )

    The dial-in number for financial analysts in North America is +1-866-259-1024 or +1-703-639-1218 for international analysts. To participate, please dial in a few minutes before the scheduled time. Employees, the media and the public are invited to listen to the call at savvis.net. A supporting presentation will also be available at savvis.net on the Investor Relations page.

    A replay of the call will be available through Wednesday, November 11, by dialing +1-888-266-2081 in North America or +1-703-925-2533 internationally and using the access code 1404087. A webcast replay will also be archived for a limited period on the company's Web site at savvis.net.

    About Savvis

    Savvis, Inc. (Nasdaq: SVVS) is a global leader in outsourced internet infrastructure services for enterprises. More than 4,000 customers, including 40 percent of the top 100 companies in the Fortune 500, use Savvis to reduce capital expense, improve service levels and harness the latest advances in cloud computing. For more information visit www.savvis.net .

    Savvis, Inc.

    Investors: Peggy Reilly Tharp, +1-314-628-7491, peggy.tharp@savvis.net: or Media: Carter Cromley, +1-703-667-6110, carter.cromley@savvis.net, both of Savvis, Inc.




    Land Star Inc (LDSR) No Recapitalization and No Dilution Policy In EffectCompany Featured On StockProfile.Com

    WUHAN, China, Oct. 13 /PRNewswire-FirstCall/ -- HTDS http://www.landstarcorp.com/ (LDSR) further to the company news release of August 11 2009 where amongst other things Mr. Lee Congtang, CEO, Chairman, said, "Sometime next week after the market has had the time to absorb our recent news events, and had time to digest our financial statements which we will be shortly filing, LDSR intends to call a meeting of our board of directors and advisors to pass certain board resolutions regarding our proposed no recapitalization and no dilution policy." The company is pleased to report that this policy has been adopted and is in full force and effect. The company operates entirely on its cash flows from day to day operations and natural organic means. The company's financial audit continues with its aspirations to become an OTCBB qualified company.

    The company is also using this opportunity to announce that it has joined http://www.stockprofile.com/, a customized web-based platform showcasing emerging growth stocks.

    StockProfile.com provides the investing public with a free unique information portal for investors who like to conduct their own research and make their own investment decisions. The platform allows users to review and investigate dynamic publicly traded companies in a user-friendly environment.

    If you are interested in viewing LDSR profile, please visit http://www.stockprofile.com/.

    To receive regular updates on LDSR please sign up or opt in with your email address at this link http://www.minamargroup.com/updates/

    Safe Harbor Statement

    Information in this news release may contain statements about future expectations, plans, prospects or performance of Land Star, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. Land Star, Inc. cautions you that any forward-looking information provided by or on behalf of Land Star, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Land Star, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Land Star, Inc.'s control. In addition to those discussed in Land Star, Inc.'s press releases, public filings, and statements by Land Star, Inc.'s management, including, but not limited to, Land Star, Inc.'s estimate of the sufficiency of its existing capital resources, Land Star, Inc.'s ability to raise additional capital to fund future operations, Land Star, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Land Star, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Land Star, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

    CONTACT: CONTACT: For any investor relations matters, please contact http://www.minamargroup.net/helpdesk; Investor Relations Department, (302) 357-9915 (IR), 1st Level Support Retail Clients General Inquiry, http://www.minamargroup.net/ (IR); For (M&A) and Corporate Matters, 1-800-365-4331, http://www.minamargroup.com/

    Land Star Inc.

    CONTACT: CONTACT: For any investor relations matters, please contact
    http://www.minamargroup.net/helpdesk; Investor Relations Department, (302) 357-9915
    (IR), 1st Level Support Retail Clients General Inquiry, http://www.minamargroup.net/
    (IR); For (M&A) and Corporate Matters, 1-800-365-4331, http://www.minamargroup.com/

    page 1     page 2     page 3     page 4     page 5     page 6     page 7     page 8     page 9     page 10     page 11     page 12    

    News archive of October 2017
    1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31 



    News Archives of October 2009
    1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31  

    News Archives other dates
        2017:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2016:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2015:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2014:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2013:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2012:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2011:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2010:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2009:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2008:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2007:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
        2006:   Jan     Feb     Mar     Apr     May     Jun     Jul     Aug     Sep     Oct     Nov     Dec    
  •  
    0-C     D-L     M-R     S-Z